<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>ADVAT</title>
  <link rel="stylesheet" href="style.css">
  <script src="https://kit.fontawesome.com/c993345b5e.js" crossorigin="anonymous"></script>
</head>
<body>
    <div class="container-fluid header-wrapper">
		<div class="col-xs-8">
			<div class="logo">
				<img src="pic2.png" alt="logo">
			</div>
			<span class="logotext"><b>Gene Coverage Metrics</b></span>
		</div>
	</div>
  <div class="container">
    
    <table id="dataTable">
      <thead>

							<tr>
								<td colspan="3">
									<h1 style="float: left;">Gene Coverage Table <br><span>(ADVAT Focus Carrier Screening Panel)</span></h1>
									<input type="text" id="searchInput" placeholder="Search...">
									
								</td>
								</td>
							</tr>
							<tr class="header">
								<th>Disease Condition</th>
								<th>Gene
									</th>
								<th>Inhertiance  \  Omim ID
									</th>
							</tr>
						
        
      </thead>
      <tbody>
        <tr>
            <td>Ataxia-Telangiectasia</td>
            <td>ATM</td>
            <td>AR \ 208900</td>
        </tr>
	<tr>
            <td>Harel-Yoon syndrome and Pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal</td>
            <td>ATAD3A</td>
            <td>AR \ 617183,618810</td>
        </tr>
        <tr>
            <td>Bardet-Biedl Syndrome 4</td>
            <td>BBS4</td>
            <td>AR \ 615982</td>
        </tr>
        <tr>
            <td>Mental retardation, autosomal recessive 3</td>
            <td>CC2D1A</td>
            <td>AR \ 608443</td>
        </tr>
        <tr>
            <td>Cystic Fibrosis</td>
            <td>CFTR</td>
            <td>AR \ 219700</td>
        </tr>
        <tr>
            <td>Ceroid Lipofuscinosis, Neuronal, 3</td>
            <td>CLN3</td>
            <td>AR \ 204200</td>
        </tr>
        <tr>
            <td>Cystinosis</td>
            <td>CTNS</td>
            <td>AR \  219800, 219900, 219750</td>
        </tr>
        <tr>
            <td>Duchenne/Becker Muscular Dystrophy</td>
            <td>DMD</td>
            <td>XLR \ 310200</td>
        </tr>
        <tr>
            <td>Fanconi Anemia, Group A</td>
            <td>FANCA</td>
            <td>AR \ 227650</td>
        </tr>
        <tr>
            <td>Fanconi Anemia, Group C</td>
            <td>FANCC</td>
            <td>AR \ 227645</td>
        </tr>
        <tr>
            <td>Glycogen Storage Disease, Type II (Pompe Disease)</td>
            <td>GAA</td>
            <td>AR \ 232300</td>
        </tr>
        <tr>
            <td>Krabbe Disease</td>
            <td>GALC</td>
            <td>AR \ 245200</td>
        </tr>
        <tr>
            <td>Galactosemia</td>
            <td>GALT</td>
            <td>AR \ 230400</td>
        </tr>
        <tr>
            <td>Isolated growth hormone deficiency, Type IA/II</td>
            <td>GH1</td>
            <td>AR \ 262400</td>
        </tr>
        <tr>
            <td>Non-Syndromic Hearing Loss (a.k.a. Connexin 26)</td>
            <td>GJB2</td>
            <td>AR \ 220290</td>
        </tr>
        <tr>
            <td>Non-Syndromic Hearing Loss (a.k.a. Connexin 30)</td>
            <td>GJB6</td>
            <td>AR \ 220290 ,612645</td>
        </tr>
        <tr>
            <td>Fabry Disease</td>
            <td>GLA</td>
            <td>XL \ 301500</td>
        </tr>
        <tr>
            <td>Beta-Hemoglobinopathies</td>
            <td>HBB</td>
            <td> \ 613985</td>
        </tr>
        <tr>
            <td>Tay-Sachs Disease</td>
            <td>HEXA</td>
            <td>AR \ 272800</td>
        </tr>
        <tr>
            <td>Glanzmann thrombasthenia</td>
            <td>ITGB3</td>
            <td>AR \ 619267</td>
        </tr>
        <tr>
            <td>Mucolipidosis, Type IV</td>
            <td>MCOLN1</td>
            <td>AR \ 252650</td>
        </tr>
        <tr>
            <td>Nemaline Myopathy, NEB-Related</td>
            <td>NEB</td>
            <td>AR \ 256030</td>
        </tr>
        <tr>
            <td>Phenylketonuria</td>
            <td>PAH</td>
            <td>AR \ 261600</td>
        </tr>
        <tr>
            <td>Usher Syndrome, Type 1F</td>
            <td>PCDH15</td>
            <td>AR \ 602083</td>
        </tr>
        <tr>
            <td>Myasthenic syndrome, congenital, 22</td>
            <td>PREPL</td>
            <td>AR \ 616224</td>
        </tr>
        <tr>
            <td>Aicardi-Goutires Syndrome</td>
            <td>SAMHD1</td>
            <td>AR \ 612952</td>
        </tr>
        <tr>
            <td>Cystinuria, Type A</td>
            <td>SLC3A1</td>
            <td>AR,AD \ 220100</td>
        </tr>
        <tr>
            <td>Deafness, autosomal recessive 16</td>
            <td>STRC</td>
            <td>AR \ 603720</td>
        </tr>
        <tr>
            <td>Usher Syndrome, Type 2A</td>
            <td>USH2A</td>
            <td>AR \ 276901</td>
        </tr>
        <tr>
            <td>Choreo-acanthocytosis</td>
            <td>VPS13A</td>
            <td>AR \ 200150</td>
        </tr>
        <tr>
            <td>Congenital Adrenal Hyperplasia, 21-hydroxylase-deficient</td>
            <td>CYP21A2</td>
            <td>AR \ 201910</td>
        </tr>
        <tr>
            <td>Alpha-Thalassemia</td>
            <td>HBA1</td>
            <td> \ 604131</td>
        </tr>
        <tr>
            <td>Alpha-Thalassemia</td>
            <td>HBA2</td>
            <td> \ 604131</td>
        </tr>
	<tr>
            <td>Carpenter syndrome 2</td>
            <td>MEGF8</td>
            <td>AR \ 614976</td>
        </tr>
        <tr>
            <td>Spinal Muscular Atrophy</td>
            <td>SMN1</td>
            <td>AR \ 253300 , 253550 ,253400,  271150</td>
        </tr>
	<tr>
            <td>Congenital heart defects, multiple types, 9</td>
            <td>PLXND1</td>
            <td>AR \ 620294</td>
        </tr>
	 <tr>
            <td>Heart and brain malformation syndrome and Neurodevelopmental disorder with intention tremor, pyramidal signs, dyspraxia, and ocular anomaliesSpastic paraplegia 11, autosomal recessive</td>
            <td>SMG9</td>
            <td>AR \ 602099,616668,604360</td>
        </tr>
	  <tr>
            <td>Deafness, autosomal recessive 37</td>
            <td>MYO6</td>
            <td>AR \ 607821</td>
        </tr>
	 <tr>
            <td>Amyotrophic lateral sclerosis 5, juvenile Charcot-Marie-Tooth disease, axonal, type 2X</td>
            <td>SPG11</td>
            <td>AR \ 602099,619995</td>
        </tr>
        <tr>
            <td>Achalasia-Addisonianism-Alacrima Syndrome</td>
            <td>AAAS</td>
            <td>AR \ 231550</td>
        </tr>
        <tr>
            <td>Harlequin ichthyosis</td>
            <td>ABCA12</td>
            <td>AR \ 242500</td>
        </tr>
        <tr>
            <td>Stargardt Disease, Type 1</td>
            <td>ABCA4</td>
            <td>AR \ 248200</td>
        </tr>
        <tr>
            <td>Progressive Familial Intrahepatic Cholestasis, Type 2</td>
            <td>ABCB11</td>
            <td>AR \ 601847</td>
        </tr>
        <tr>
            <td>Progressive Familial Intrahepatic Cholestasis, Type 3</td>
            <td>ABCB4</td>
            <td>AR \ 602347</td>
        </tr>
        <tr>
            <td>Pseudoxanthoma elasticum</td>
            <td>ABCC6</td>
            <td>AR \ 264800</td>
        </tr>
        <tr>
            <td>Familial Hyperinsulinism, ABCC8-Related</td>
            <td>ABCC8</td>
            <td>AD, AR \ 256450</td>
        </tr>
        <tr>
            <td>Adrenoleukodystrophy, X-Linked</td>
            <td>ABCD1</td>
            <td>XLR \ 300100</td>
        </tr>
        <tr>
            <td>Mitochondrial Complex I Deficiency, ACAD9-Related</td>
            <td>ACAD9</td>
            <td>AR \ 611126</td>
        </tr>
        <tr>
            <td>Medium Chain Acyl-CoA Dehydrogenase Deficiency</td>
            <td>ACADM</td>
            <td>AR \ 201450</td>
        </tr>
        <tr>
            <td>Short Chain Acyl-CoA Dehydrogenase Deficiency</td>
            <td>ACADS</td>
            <td>AR \ 201470</td>
        </tr>
        <tr>
            <td>Short/branched chain acyl-CoA dehydrogenase</td>
            <td>ACADSB</td>
            <td>AR \ 610006</td>
        </tr>
        <tr>
            <td>Very Long-Chain Acyl-CoA Dehydrogenase Deficiency</td>
            <td>ACADVL</td>
            <td>AR \ 201475</td>
        </tr>
	<tr>
            <td>Ciliary dyskinesia, primary, 7, with or without situs inversus</td>
            <td>DNAH11</td>
            <td>AR \ 611884</td>
        </tr>
        <tr>
            <td>Beta-Ketothiolase Deficiency</td>
            <td>ACAT1</td>
            <td>AR \ 203750</td>
        </tr>
        <tr>
            <td>Acyl-CoA Oxidase I Deficiency</td>
            <td>ACOX1</td>
            <td>AR \ 264470</td>
        </tr>
        <tr>
            <td>Combined Malonic and Methylmalonic Aciduria</td>
            <td>ACSF3</td>
            <td>AR \ 614265</td>
        </tr>
        <tr>
            <td>Severe Combined Immunodeficiency, ADA-Related</td>
            <td>ADA</td>
            <td>AR,So \ 102700</td>
        </tr>
        <tr>
            <td>Ehlers-Danlos Syndrome, Type VIIC</td>
            <td>ADAMTS2</td>
            <td>AR \ 225410</td>
        </tr>
        <tr>
            <td>Bilateral Frontoparietal Polymicrogyria</td>
            <td>ADGRG1</td>
            <td>AR \ 606854</td>
        </tr>
        <tr>
            <td>Aspartylglucosaminuria</td>
            <td>AGA</td>
            <td>AR \ 208400</td>
        </tr>
        <tr>
            <td>Glycogen Storage Disease, Type III (Cori/Forbes)</td>
            <td>AGL</td>
            <td>AR \ 232400</td>
        </tr>
        <tr>
            <td>Rhizomelic Chondrodysplasia Punctata, Type 3</td>
            <td>AGPS</td>
            <td>AR \ 600121</td>
        </tr>
        <tr>
            <td>Hyperoxaluria, Primary, Type 1</td>
            <td>AGXT</td>
            <td>AR \ 259900</td>
        </tr>
        <tr>
            <td>Autoimmune polyendocrinopathy syndrome, type I</td>
            <td>AIRE</td>
            <td>AD, AR \ 240300</td>
        </tr>
        <tr>
            <td>Sjogren-Larsson Syndrome</td>
            <td>ALDH3A2</td>
            <td>AR \ 270200</td>
        </tr>
        <tr>
            <td>Pyridoxine-dependent epilepsy</td>
            <td>ALDH7A1</td>
            <td>AR \ 266100</td>
        </tr>
        <tr>
            <td>Hereditary Fructose Intolerance</td>
            <td>ALDOB</td>
            <td>AR \ 229600</td>
        </tr>
        <tr>
            <td>Congenital Disorder of Glycosylation, Type 1C</td>
            <td>ALG6</td>
            <td>AR \ 603147</td>
        </tr>
        <tr>
            <td>Alstrom Syndrome</td>
            <td>ALMS1</td>
            <td>AR \ 203800</td>
        </tr>
        <tr>
            <td>Hypophosphatasia, ALPL-Related</td>
            <td>ALPL</td>
            <td>AD, AR \ 146300 ,241510 , 241500, 146300</td>
        </tr>
        <tr>
            <td>Persistent Müllerian duct syndrome type 1</td>
            <td>AMH</td>
            <td>AR \ 261550</td>
        </tr>
        <tr>
            <td>Persistent Müllerian duct syndrome type 2</td>
            <td>AMHR2</td>
            <td>AR \ 261550</td>
        </tr>
        <tr>
            <td>Glycine Encephalopathy, AMT-Related</td>
            <td>AMT</td>
            <td> \ 620398</td>
        </tr>
        <tr>
            <td>Mental retardation, enteropathy, deafness, peripheral neuropathy, ichthyosis, and keratoderma (MEDNIK)</td>
            <td>AP1S1</td>
            <td>AR \ 609313</td>
        </tr>
        <tr>
            <td>Familial Nephrogenic Diabetes Insipidus, AQP2-Related</td>
            <td>AQP2</td>
            <td>AD, AR \ 125800</td>
        </tr>
        <tr>
            <td>Androgen insensitivity syndrome, X-Linked</td>
            <td>AR</td>
            <td>XLR \ 300068</td>
        </tr>
        <tr>
            <td>Argininemia</td>
            <td>ARG1</td>
            <td>AR \ 207800</td>
        </tr>
        <tr>
            <td>Metachromatic Leukodystrophy, ARSA-Related</td>
            <td>ARSA</td>
            <td>AR \ 250100</td>
        </tr>
        <tr>
            <td>Mucopolysaccharidosis, Type VI (Maroteaux-Lamy)</td>
            <td>ARSB</td>
            <td>AR \ 253200</td>
        </tr>
        <tr>
            <td>Argininosuccinate Lyase Deficiency</td>
            <td>ASL</td>
            <td>AR \ 207900</td>
        </tr>
        <tr>
            <td>Asparagine Synthetase Deficiency</td>
            <td>ASNS</td>
            <td>AR \ 615574</td>
        </tr>
        <tr>
            <td>Canavan Disease</td>
            <td>ASPA</td>
            <td>AR \ 271900</td>
        </tr>
        <tr>
            <td>Citrullinemia, Type 1</td>
            <td>ASS1</td>
            <td>AR \ 215700</td>
        </tr>
	<tr>
            <td>Spermatogenic failure 46</td>
            <td>DNAH8</td>
            <td>AR \ 603337</td>
        </tr>
        <tr>
            <td>Renal Tubular Acidosis and Deafness, ATP6V1B1-Related</td>
            <td>ATP6V1B1</td>
            <td>AR \ 267300</td>
        </tr>
        <tr>
            <td>Menkes Syndrome, X-Linked</td>
            <td>ATP7A</td>
            <td>AR \ 309400</td>
        </tr>
        <tr>
            <td>Wilson Disease</td>
            <td>ATP7B</td>
            <td>AR \ 277900</td>
        </tr>
        <tr>
            <td>Progressive Familial Intrahepatic Cholestasis, Type 1</td>
            <td>ATP8B1</td>
            <td>AR \ 211600</td>
        </tr>
        <tr>
            <td>Alpha-Thalassemia Intellectual Disability Syndrome, X-Linked</td>
            <td>ATRX</td>
            <td>XLD \ 301040</td>
        </tr>
        <tr>
            <td>Bardet-Biedl Syndrome 1</td>
            <td>BBS1</td>
            <td>AR, DR \ 209900</td>
        </tr>
        <tr>
            <td>Bardet-Biedl Syndrome 10</td>
            <td>BBS10</td>
            <td>AR \ 615987</td>
        </tr>
        <tr>
            <td>Bardet-Biedl Syndrome 12</td>
            <td>BBS12</td>
            <td>AR \ 615989</td>
        </tr>
        <tr>
            <td>Bardet-Biedl Syndrome 2</td>
            <td>BBS2</td>
            <td>AR \ 615981</td>
        </tr>
        <tr>
            <td>Bardet-Biedl Syndrome 9</td>
            <td>BBS9</td>
            <td>AR \ 615986</td>
        </tr>
        <tr>
            <td>Pseudocholinesterase Deficiency</td>
            <td>BCHE</td>
            <td>AR \ 617936</td>
        </tr>
        <tr>
            <td>Maple Syrup Urine Disease, Type 1A</td>
            <td>BCKDHA</td>
            <td>AR \ 248600</td>
        </tr>
        <tr>
            <td>Maple Syrup Urine Disease, Type 1B</td>
            <td>BCKDHB</td>
            <td>AR \ 620698</td>
        </tr>
        <tr>
            <td>GRACILE Syndrome</td>
            <td>BCS1L</td>
            <td>AR \ 603358</td>
        </tr>
        <tr>
            <td>Bloom Syndrome</td>
            <td>BLM</td>
            <td>AR \ 210900</td>
        </tr>
        <tr>
            <td>Fanconi anemia, Group J</td>
            <td>BRIP1</td>
            <td> \ 609054</td>
        </tr>
        <tr>
            <td>Bartter syndrome, Type 4a</td>
            <td>BSND</td>
            <td>AR \ 602522</td>
        </tr>
        <tr>
            <td>Biotinidase Deficiency</td>
            <td>BTD</td>
            <td>AR \ 253260</td>
        </tr>
        <tr>
            <td>Isolated growth hormone deficiency, Type III, X-linked</td>
            <td>BTK</td>
            <td>XLR \ 307200</td>
        </tr>
        <tr>
            <td>Desbuquois dysplasia 1</td>
            <td>CANT1</td>
            <td>AR \ 251450</td>
        </tr>
        <tr>
            <td>Limb-Girdle Muscular Dystrophy, Type 2A</td>
            <td>CAPN3</td>
            <td>AR \ 253600</td>
        </tr>
        <tr>
            <td>Catecholaminergic polymorphic ventricular tachycardia</td>
            <td>CASQ2</td>
            <td>AR \ 611938</td>
        </tr>
        <tr>
            <td>Homocystinuria, CBS-Related</td>
            <td>CBS</td>
            <td>AR \ 236200</td>
        </tr>
        <tr>
            <td>Usher Syndrome, Type 1D</td>
            <td>CDH23</td>
            <td>AR, DR \ 601067</td>
        </tr>
        <tr>
            <td>Leber Congenital Amaurosis, Type CEP290</td>
            <td>CEP290</td>
            <td> \ 611755</td>
        </tr>
        <tr>
            <td>Retinitis Pigmentosa 26</td>
            <td>CERKL</td>
            <td>AR \ 608380</td>
        </tr>
        <tr>
            <td>Choroideremia, X-Linked</td>
            <td>CHM</td>
            <td>XL \ 303100</td>
        </tr>
        <tr>
            <td>Congenital Myasthenic Syndrome, CHRNE-Related</td>
            <td>CHRNE</td>
            <td>AD, AR \ 605809, 616324,  608931</td>
        </tr>
        <tr>
            <td>Escobar Syndrome</td>
            <td>CHRNG</td>
            <td>AR \ 265000</td>
        </tr>
        <tr>
            <td>Bare Lymphocyte Syndrome, CIITA-Related</td>
            <td>CIITA</td>
            <td>AR \ 209920</td>
        </tr>
        <tr>
            <td>Ceroid Lipofuscinosis, Neuronal, 5</td>
            <td>CLN5</td>
            <td>AR \ 256731</td>
        </tr>
        <tr>
            <td>Ceroid Lipofuscinosis, Neuronal, 6</td>
            <td>CLN6</td>
            <td>AR \ 601780, 204300</td>
        </tr>
        <tr>
            <td>Ceroid Lipofuscinosis, Neuronal, 8 (a.ka. Northern Epilepsy)</td>
            <td>CLN8</td>
            <td>AR \ 610003</td>
        </tr>
        <tr>
            <td>Usher Syndrome, Type 3</td>
            <td>CLRN1</td>
            <td>AR \ 276902</td>
        </tr>
        <tr>
            <td>Achromatopsia, CNGA3-Related</td>
            <td>CNGA3</td>
            <td>AR \ 216900</td>
        </tr>
        <tr>
            <td>Achromatopsia, CNGB3-Related</td>
            <td>CNGB3</td>
            <td>AR \ 262300</td>
        </tr>
        <tr>
            <td>Fibrochondrogenesis type 2</td>
            <td>COL11A2</td>
            <td>AD, AR \ 614524</td>
        </tr>
        <tr>
            <td>Alport Syndrome, COL4A3-Related</td>
            <td>COL4A3</td>
            <td>AR \ 620536</td>
        </tr>
        <tr>
            <td>Alport Syndrome, COL4A4-Related</td>
            <td>COL4A4</td>
            <td>AR \ 203780</td>
        </tr>
        <tr>
            <td>Alport Syndrome, X-Linked</td>
            <td>COL4A5</td>
            <td>XLD \ 301050</td>
        </tr>
        <tr>
            <td>Dystrophic Epidermolysis Bullosa, COL7A1-Related</td>
            <td>COL7A1</td>
            <td>AR \ 226600</td>
        </tr>
        <tr>
            <td>Carbamoyl Phosphate Synthetase I Deficiency</td>
            <td>CPS1</td>
            <td>AR \ 237300</td>
        </tr>
        <tr>
            <td>Carnitine Palmitoyltransferase IA Deficiency</td>
            <td>CPT1A</td>
            <td>AR \ 255120</td>
        </tr>
        <tr>
            <td>Carnitine Palmitoyltransferase II Deficiency</td>
            <td>CPT2</td>
            <td>AD, AR \ 600649, 600649, 255110</td>
        </tr>
        <tr>
            <td>Leber congenital amaurosis 8</td>
            <td>CRB1</td>
            <td>AR \ 613835</td>
        </tr>
        <tr>
            <td>Papillon-Lefevre Syndrome</td>
            <td>CTSC</td>
            <td>AR \ 245000</td>
        </tr>
        <tr>
            <td>Ceroid Lipofuscinosis, Neuronal, 10 (CLN10 Disease)</td>
            <td>CTSD</td>
            <td>AR \ 610127</td>
        </tr>
        <tr>
            <td>Pycnodysostosis</td>
            <td>CTSK</td>
            <td>AR \ 265800</td>
        </tr>
        <tr>
            <td>Chronic Granulomatous Disease, CYBA-Related</td>
            <td>CYBA</td>
            <td>AR \ 233690</td>
        </tr>
        <tr>
            <td>Chronic Granulomatous Disease, X-Linked</td>
            <td>CYBB</td>
            <td>XLR \ 306400</td>
        </tr>
        <tr>
            <td>Congenital Adrenal Hyperplasia, 11-beta-hydroxylase-deficient</td>
            <td>CYP11B1</td>
            <td>AR \ 202010</td>
        </tr>
        <tr>
            <td>Corticosterone Methyloxidase Deficiency</td>
            <td>CYP11B2</td>
            <td>AR \ 203400, 610600</td>
        </tr>
	<tr>
            <td>?Deafness, autosomal recessive 61</td>
            <td>SLC26A5</td>
            <td>AR \ 613865</td>
        </tr>
	<tr>
            <td>Charcot-Marie-Tooth disease, axonal, type 2A2B and Lipomatosis, multiple symmetric, with or without peripheral neuropathy</td>
            <td>MFN2</td>
            <td>AR \ 617087,151800</td>
        </tr>
        <tr>
            <td>Congenital Adrenal Hyperplasia, 17-Alpha-Hydroxylase Deficiency</td>
            <td>CYP17A1</td>
            <td>AR \ 202110</td>
        </tr>
	 <tr>
            <td>Retinitis pigmentosa 78</td>
            <td>ARHGEF18</td>
            <td>AR \ 617433</td>
        </tr>
        <tr>
            <td>Aromatase Deficiency</td>
            <td>CYP19A1</td>
            <td> \ 613546</td>
        </tr>
        <tr>
            <td>Primary Congenital Glaucoma</td>
            <td>CYP1B1</td>
            <td>AR \ 231300</td>
        </tr>
        <tr>
            <td>Cerebrotendinous Xanthomatosis</td>
            <td>CYP27A1</td>
            <td>AR \ 213700</td>
        </tr>
        <tr>
            <td>Vitamin D-dependent rickets type 1A</td>
            <td>CYP27B1</td>
            <td>AR \ 264700</td>
        </tr>
        <tr>
            <td>Maple Syrup Urine Disease, Type 2</td>
            <td>DBT</td>
            <td>AR \ 620699</td>
        </tr>
        <tr>
            <td>Severe Combined Immunodeficiency, Type Athabaskan</td>
            <td>DCLRE1C</td>
            <td>AR \ 602450</td>
        </tr>
        <tr>
            <td>Xeroderma Pigmentosum Group E</td>
            <td>DDB2</td>
            <td>AR \ 278740</td>
        </tr>
        <tr>
            <td>Smith-Lemli-Opitz Syndrome</td>
            <td>DHCR7</td>
            <td>AR \ 270400</td>
        </tr>
        <tr>
            <td>Retinitis Pigmentosa 59</td>
            <td>DHDDS</td>
            <td>AR \ 613861</td>
        </tr>
        <tr>
            <td>Dyskeratosis congenita, X-Linked</td>
            <td>DKC1</td>
            <td>AR \ 305000</td>
        </tr>
        <tr>
            <td>Dihydrolipoamide Dehydrogenase Deficiency</td>
            <td>DLD</td>
            <td>AR \ 246900</td>
        </tr>
        <tr>
            <td>Ciliary Dyskinesia, Primary 3</td>
            <td>DNAH5</td>
            <td>AR \ 608644</td>
        </tr>
        <tr>
            <td>Ciliary Dyskinesia, Primary 1</td>
            <td>DNAI1</td>
            <td>AR \ 244400</td>
        </tr>
        <tr>
            <td>Ciliary Dyskinesia, Primary 9</td>
            <td>DNAI2</td>
            <td>AR \ 612444</td>
        </tr>
        <tr>
            <td>Ciliary Dyskinesia, Primary, 16</td>
            <td>DNAL1</td>
            <td>AR \ 614017</td>
        </tr>
        <tr>
            <td>Congenital Myasthenic Syndrome, DOK7-Related</td>
            <td>DOK7</td>
            <td>AR \ 254300</td>
        </tr>
        <tr>
            <td>Dihydropyrimidine Dehydrogenase Deficiency</td>
            <td>DPYD</td>
            <td>AR \ 274270</td>
        </tr>
        <tr>
            <td>Limb-Girdle Muscular Dystrophy, Type 2B</td>
            <td>DYSF</td>
            <td>AR \ 253601</td>
        </tr>
        <tr>
            <td>Hypohidrotic Ectodermal Dysplasia, X-Linked</td>
            <td>EDA</td>
            <td>AR \ 305100</td>
        </tr>
        <tr>
            <td>Hypohidrotic Ectodermal Dysplasia</td>
            <td>EDAR</td>
            <td>AR \ 224900</td>
        </tr>
        <tr>
            <td>Wolcott-Rallison Syndrome</td>
            <td>EIF2AK3</td>
            <td>AR \ 226980</td>
        </tr>
        <tr>
            <td>Leukoencephalopathy with Vanishing White Matter</td>
            <td>EIF2B5</td>
            <td>AR \ 620315</td>
        </tr>
        <tr>
            <td>Dysautonomia, familial (IKBKAP or ELP1)</td>
            <td>IKBKAP</td>
            <td>AR \ 223900</td>
        </tr>
        <tr>
            <td>Emery-Dreifuss Muscular Dystrophy 1, X-Linked</td>
            <td>EMD</td>
            <td>XLR \ 310300</td>
        </tr>
        <tr>
            <td>Xeroderma Pigmentosum Group D</td>
            <td>ERCC2</td>
            <td>AR \ 278730</td>
        </tr>
        <tr>
            <td>Xeroderma Pigmentosum Group B</td>
            <td>ERCC3</td>
            <td>AR \ 610651</td>
        </tr>
        <tr>
            <td>Xeroderma Pigmentosum Group F</td>
            <td>ERCC4</td>
            <td>AR \ 278760</td>
        </tr>
        <tr>
            <td>Xeroderma pigmentosum Group G</td>
            <td>ERCC5</td>
            <td>AR \ 278780</td>
        </tr>
        <tr>
            <td>Cockayne syndrome, type B</td>
            <td>ERCC6</td>
            <td>AR \ 133540</td>
        </tr>
        <tr>
            <td>Cockayne syndrome, type A</td>
            <td>ERCC8</td>
            <td>AR \ 216400</td>
        </tr>
        <tr>
            <td>Roberts Syndrome</td>
            <td>ESCO2</td>
            <td>AR \ 268300</td>
        </tr>
        <tr>
            <td>Glutaric Acidemia, Type 2A</td>
            <td>ETFA</td>
            <td>AR \ 231680</td>
        </tr>
        <tr>
            <td>Glutaric Acidemia, Type 2B</td>
            <td>ETFB</td>
            <td>AR \ 231680</td>
        </tr>
        <tr>
            <td>Glutaric Acidemia, Type 2C</td>
            <td>ETFDH</td>
            <td>AR \ 231680</td>
        </tr>
        <tr>
            <td>Ethylmalonic Encephalopathy</td>
            <td>ETHE1</td>
            <td>AR \ 602473</td>
        </tr>
        <tr>
            <td>Ellis-van Creveld Syndrome, EVC-Related</td>
            <td>EVC</td>
            <td>AR \ 225500</td>
        </tr>
        <tr>
            <td>Ellis-van Creveld Syndrome, EVC2-related</td>
            <td>EVC2</td>
            <td>AR \ 225500</td>
        </tr>
        <tr>
            <td>Pontocerebellar Hypoplasia, Type 1B</td>
            <td>EXOSC3</td>
            <td>AR \ 614678</td>
        </tr>
        <tr>
            <td>Retinitis Pigmentosa 25</td>
            <td>EYS</td>
            <td>AR \ 602772</td>
        </tr>
        <tr>
            <td>Factor XI deficiency</td>
            <td>F11</td>
            <td>AR \ 612416</td>
        </tr>
        <tr>
            <td>Prothrombin deficiency</td>
            <td>F2</td>
            <td>AR \ 613679</td>
        </tr>
        <tr>
            <td>Hemophilia A</td>
            <td>F8</td>
            <td>XLR \ 306700</td>
        </tr>
        <tr>
            <td>Hemophilia B</td>
            <td>F9</td>
            <td>XLR \ 306900</td>
        </tr>
        <tr>
            <td>Tyrosinemia, Type I</td>
            <td>FAH</td>
            <td>AR \ 276700</td>
        </tr>
        <tr>
            <td>Retinitis Pigmentosa 28</td>
            <td>FAM161A</td>
            <td>AR \ 606068</td>
        </tr>
        <tr>
            <td>Fanconi Anemia, Group G</td>
            <td>FANCG</td>
            <td>AR \ 614082</td>
        </tr>
        <tr>
            <td>Fumarase Deficiency</td>
            <td>FH</td>
            <td>AR \ 606812</td>
        </tr>
        <tr>
            <td>Limb-Girdle Muscular Dystrophy, Type 2I</td>
            <td>FKRP</td>
            <td>AR \ 607155</td>
        </tr>
        <tr>
            <td>Walker-Warburg Syndrome, FKTN-Related</td>
            <td>FKTN</td>
            <td>AR \ 253800</td>
        </tr>
        <tr>
            <td>Glycogen Storage Disease, Type IA</td>
            <td>G6PC</td>
            <td>AR \ 232200</td>
        </tr>
        <tr>
            <td>Glucose-6-Phosphate Dehydrogenase Deficiency*</td>
            <td>G6PD</td>
            <td>AR \ 300908</td>
        </tr>
        <tr>
            <td>Galactose epimerase deficiency</td>
            <td>GALE</td>
            <td>AR \ 230350</td>
        </tr>
        <tr>
            <td>Galactokinase Deficiency (Galactosemia, Type II)</td>
            <td>GALK1</td>
            <td>AR \ 230200</td>
        </tr>
        <tr>
            <td>Mucopolysaccharidosis, Type IVA</td>
            <td>GALNS</td>
            <td>AR \ 253000</td>
        </tr>
        <tr>
            <td>Hyperphosphatemic familial tumoral calcinosis</td>
            <td>GALNT3</td>
            <td>AR \ 211900</td>
        </tr>
        <tr>
            <td>Guanidinoacetate Methyltransferase Deficiency</td>
            <td>GAMT</td>
            <td>AR \ 612736</td>
        </tr>
        <tr>
            <td>Gaucher Disease</td>
            <td>GBA</td>
            <td>AR \ 230800, 230900 , 231000, 231005</td>
        </tr>
        <tr>
            <td>Glycogen Storage Disease, Type IV</td>
            <td>GBE1</td>
            <td>AR \ 232500</td>
        </tr>
        <tr>
            <td>Glutaric Acidemia, Type 1</td>
            <td>GCDH</td>
            <td>AR \ 231670</td>
        </tr>
        <tr>
            <td>Dopa-responsive dystonia</td>
            <td>GCH1</td>
            <td>AD,AR \ 128230</td>
        </tr>
        <tr>
            <td>Grebe syndrome</td>
            <td>GDF5</td>
            <td>AR \ 200700</td>
        </tr>
        <tr>
            <td>Combined Oxidative Phosphorylation Deficiency 1</td>
            <td>GFM1</td>
            <td>AR \ 609060</td>
        </tr>
        <tr>
            <td>Isolated growth hormone deficiency, Type IB</td>
            <td>GHRHR</td>
            <td>AR \ 618157</td>
        </tr>
        <tr>
            <td>Charcot-Marie-Tooth Disease with Deafness, X-Linked</td>
            <td>GJB1</td>
            <td>XLD \ 302800</td>
        </tr>
        <tr>
            <td>Erythrokeratodermia variabilis et progressiva</td>
            <td>GJB3</td>
            <td>AD,AR \ 133200</td>
        </tr>
        <tr>
            <td>Mucopolysaccharidosis, Type IVB / GM1 Gangliosidosis</td>
            <td>GLB1</td>
            <td>AR \ 253010</td>
        </tr>
        <tr>
            <td>Glycine Encephalopathy, GLDC-Related</td>
            <td>GLDC</td>
            <td>AR \ 605899</td>
        </tr>
        <tr>
            <td>Lethal Congenital Contracture Syndrome 1</td>
            <td>GLE1</td>
            <td>AR \ 253310</td>
        </tr>
        <tr>
            <td>Inclusion Body Myopathy 2</td>
            <td>GNE</td>
            <td>AR \ 620757</td>
        </tr>
        <tr>
            <td>Mucolipidosis II/IIIA</td>
            <td>GNPTAB</td>
            <td>AR \ 252500, 252600</td>
        </tr>
        <tr>
            <td>Mucolipidosis III gamma</td>
            <td>GNPTG</td>
            <td>AR \ 252605</td>
        </tr>
        <tr>
            <td>Mucopolysaccharidosis, Type IIID (Sanfilippo D)</td>
            <td>GNS</td>
            <td>AR \ 252940</td>
        </tr>
        <tr>
            <td>Geroderma osteodysplastica</td>
            <td>GORAB</td>
            <td>AR \ 231070</td>
        </tr>
        <tr>
            <td>Bernard-Soulier Syndrome, Type A2</td>
            <td>GP1BA</td>
            <td>AD \ 153670</td>
        </tr>
        <tr>
            <td>Bernard-Soulier Syndrome, Type B</td>
            <td>GP1BB</td>
            <td>AR \ 231200</td>
        </tr>
        <tr>
            <td>Bernard-Soulier Syndrome, Type C</td>
            <td>GP9</td>
            <td>AR \ 231200</td>
        </tr>
        <tr>
            <td>Primary Hyperoxaluria, Type 2</td>
            <td>GRHPR</td>
            <td>AR \ 260000</td>
        </tr>
        <tr>
            <td>Leber congenital amaurosis 1</td>
            <td>GUCY2D</td>
            <td>AR \ 204000</td>
        </tr>
        <tr>
            <td>Mucopolysaccharidosis, Type VII</td>
            <td>GUSB</td>
            <td>AR \ 253220</td>
        </tr>
        <tr>
            <td>Long Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency</td>
            <td>HADHA</td>
            <td>AR \ 609016</td>
        </tr>
        <tr>
            <td>Trifunctional protein deficiency</td>
            <td>HADHB</td>
            <td>AR \ 620300</td>
        </tr>
        <tr>
            <td>Congenital Neutropenia, HAX1-Related</td>
            <td>HAX1</td>
            <td>AR \ 610738</td>
        </tr>
        <tr>
            <td>Sandhoff Disease</td>
            <td>HEXB</td>
            <td>AR \ 268800</td>
        </tr>
        <tr>
            <td>Hemochromatosis, Type 1</td>
            <td>HFE</td>
            <td>AR \ 235200</td>
        </tr>
        <tr>
            <td>Hemochromatosis, Type 2A</td>
            <td>HFE2</td>
            <td>AR \ 602390</td>
        </tr>
        <tr>
            <td>Alkaptonuria</td>
            <td>HGD</td>
            <td>AR \ 203500</td>
        </tr>
        <tr>
            <td>Mucopolysaccharidosis, Type IIIC (Sanfilippo C)</td>
            <td>HGSNAT</td>
            <td>AR \ 252930</td>
        </tr>
        <tr>
            <td>Holocarboxylase Synthetase Deficiency</td>
            <td>HLCS</td>
            <td>AR \ 253270</td>
        </tr>
        <tr>
            <td>3-Hydroxy-3-Methylglutaryl-Coenzyme A Lyase Deficiency</td>
            <td>HMGCL</td>
            <td>AR \ 246450</td>
        </tr>
        <tr>
            <td>Heme Oxygenase-1 Deficiency</td>
            <td>HMOX1</td>
            <td>AR \ 614034</td>
        </tr>
        <tr>
            <td>Primary Hyperoxaluria, Type 3</td>
            <td>HOGA1</td>
            <td>AR \ 613616</td>
        </tr>
        <tr>
            <td>Tyrosinemia, Type III</td>
            <td>HPD</td>
            <td>AR \ 276710</td>
        </tr>
        <tr>
            <td>Hermansky-Pudlak Syndrome 1</td>
            <td>HPS1</td>
            <td>AR \ 203300</td>
        </tr>
        <tr>
            <td>Hermansky-Pudlak Syndrome 3</td>
            <td>HPS3</td>
            <td>AR \ 614072</td>
        </tr>
        <tr>
            <td>Hermansky-Pudlak syndrome 4</td>
            <td>HPS4</td>
            <td>AR \ 614073</td>
        </tr>
        <tr>
            <td>17-beta hydroxysteroid dehydrogenase 3 deficiency</td>
            <td>HSD17B3</td>
            <td>AR \ 264300</td>
        </tr>
        <tr>
            <td>D-Bifunctional Protein Deficiency</td>
            <td>HSD17B4</td>
            <td>AR \ 261515</td>
        </tr>
        <tr>
            <td>3-Beta-Hydroxysteroid Dehydrogenase Type II Deficiency</td>
            <td>HSD3B2</td>
            <td>AR \ 201810</td>
        </tr>
        <tr>
            <td>Hydrolethalus Syndrome</td>
            <td>HYLS1</td>
            <td>AR \ 236680</td>
        </tr>
        <tr>
            <td>Mucopolysaccharidosis, Type II (Hunter Syndrome)</td>
            <td>IDS</td>
            <td>XLR \ 309900</td>
        </tr>
        <tr>
            <td>Mucopolysaccharidosis, Type I (Hurler Syndrome)</td>
            <td>IDUA</td>
            <td>AR \ 607014</td>
        </tr>
        <tr>
            <td>Severe Combined Immunodeficiency, X-Linked</td>
            <td>IL2RG</td>
            <td>XLR \ 300400</td>
        </tr>
        <tr>
            <td>Isovaleric Acidemia</td>
            <td>IVD</td>
            <td>AR \ 243500</td>
        </tr>
        <tr>
            <td>Congenital Hyperinsulinism, KCNJ11-Related</td>
            <td>KCNJ11</td>
            <td>AD,AR \ 601820</td>
        </tr>
        <tr>
            <td>LAMA2-related Muscular Dystrophy</td>
            <td>LAMA2</td>
            <td>AR \ 607855, 618138</td>
        </tr>
        <tr>
            <td>Herlitz Junctional Epidermolysis Bullosa, LAMA3-Related</td>
            <td>LAMA3</td>
            <td>AR \ 619783, 619784, 245660</td>
        </tr>
        <tr>
            <td>Herlitz Junctional Epidermolysis Bullosa, LAMB3-Related</td>
            <td>LAMB3</td>
            <td>AR \ 104530, 226650, 226700</td>
        </tr>
        <tr>
            <td>Herlitz Junctional Epidermolysis Bullosa, LAMC2-Related</td>
            <td>LAMC2</td>
            <td>AR \ 619785 , 619786</td>
        </tr>
        <tr>
            <td>Leber Congenital Amaurosis, Type LCA5</td>
            <td>LCA5</td>
            <td>AR \ 604537</td>
        </tr>
        <tr>
            <td>Familial Hypercholesterolemia, LDLR-Related</td>
            <td>LDLR</td>
            <td>AD,AR \ 143890</td>
        </tr>
        <tr>
            <td>Familial Hypercholesterolemia, LDLRAP1-Related</td>
            <td>LDLRAP1</td>
            <td>AR \ 603813</td>
        </tr>
        <tr>
            <td>Leydig cell hypoplasia</td>
            <td>LHCGR</td>
            <td>AR \ 176410, 238320, 238320, 238320</td>
        </tr>
        <tr>
            <td>Stuve-Wiedemann Syndrome</td>
            <td>LIFR</td>
            <td>AR \ 601559</td>
        </tr>
        <tr>
            <td>Lysosomal Acid Lipase Deficiency</td>
            <td>LIPA</td>
            <td>AR \ 278000, 620151</td>
        </tr>
        <tr>
            <td>Woolly Hair/Hypotrichosis Syndrome</td>
            <td>LIPH</td>
            <td>AR \ 604379</td>
        </tr>
        <tr>
            <td>Deafness, Autosomal Recessive 77</td>
            <td>LOXHD1</td>
            <td>AR \ 613079</td>
        </tr>
        <tr>
            <td>Lipoprotein Lipase Deficiency</td>
            <td>LPL</td>
            <td>AR \ 238600</td>
        </tr>
        <tr>
            <td>Leigh Syndrome, French-Canadian Type</td>
            <td>LRPPRC</td>
            <td>AR \ 220111</td>
        </tr>
        <tr>
            <td>Chediak-Higashi syndrome</td>
            <td>LYST</td>
            <td>AR \ 214500</td>
        </tr>
        <tr>
            <td>Alpha-Mannosidosis</td>
            <td>MAN2B1</td>
            <td>AR \ 248500</td>
        </tr>
        <tr>
            <td>Hypermethioninemia</td>
            <td>MAT1A</td>
            <td>AR \ 250850</td>
        </tr>
        <tr>
            <td>3-Methylcrotonyl-CoA Carboxylase 1 Deficiency</td>
            <td>MCCC1</td>
            <td>AR \ 210200</td>
        </tr>
        <tr>
            <td>3-Methylcrotonyl-CoA Carboxylase 2 Deficiency</td>
            <td>MCCC2</td>
            <td>AR \ 210210</td>
        </tr>
        <tr>
            <td>RETT Syndrome</td>
            <td>MECP2</td>
            <td>XLD \ 312750</td>
        </tr>
        <tr>
            <td>Microcephaly, postnatal progressive, with seizures and brain atrophy</td>
            <td>MED17</td>
            <td>AR \ 613668</td>
        </tr>
        <tr>
            <td>Familial Mediterranean Fever</td>
            <td>MEFV</td>
            <td>AR \ 249100</td>
        </tr>
        <tr>
            <td>Spondylothoracic Dysostosis, MESP2-Related</td>
            <td>MESP2</td>
            <td>AR \ 608681</td>
        </tr>
        <tr>
            <td>Ceroid Lipofuscinosis, Neuronal, 7</td>
            <td>MFSD8</td>
            <td>AR \ 610951</td>
        </tr>
        <tr>
            <td>Bardet-Biedl Syndrome 6</td>
            <td>MKKS</td>
            <td>AR \ 605231</td>
        </tr>
        <tr>
            <td>Meckel-Gruber Syndrome, Type 1</td>
            <td>MKS1</td>
            <td>AR \ 249000</td>
        </tr>
        <tr>
            <td>Megalencephalic Leukoencephalopathy with Subcortical Cysts</td>
            <td>MLC1</td>
            <td>AR \ 604004</td>
        </tr>
        <tr>
            <td>Malonyl-CoA decarboxylase deficiency</td>
            <td>MLYCD</td>
            <td>AR \ 248360</td>
        </tr>
        <tr>
            <td>Methylmalonic Aciduria, MMAA-Related</td>
            <td>MMAA</td>
            <td>AR \ 251100</td>
        </tr>
        <tr>
            <td>Methylmalonic Aciduria, MMAB-Related</td>
            <td>MMAB</td>
            <td>AR \ 251110</td>
        </tr>
        <tr>
            <td>Methylmalonic Aciduria and Homocystinuria, Type cblC</td>
            <td>MMACHC</td>
            <td>AR \ 277400</td>
        </tr>
        <tr>
            <td>Methylmalonic Aciduria and Homocystinuria, Type cblD</td>
            <td>MMADHC</td>
            <td>AR \ 277410</td>
        </tr>
        <tr>
            <td>Molybdenum cofactor deficiency</td>
            <td>MOCS1</td>
            <td>AR \ 252150</td>
        </tr>
        <tr>
            <td>Congenital Disorder of Glycosylation, Type 1B</td>
            <td>MPI</td>
            <td>AR \ 602579</td>
        </tr>
        <tr>
            <td>Congenital Amegakaryocytic Thrombocytopenia</td>
            <td>MPL</td>
            <td>AR \ 604498</td>
        </tr>
        <tr>
            <td>Hepatocerebral Mitochondrial DNA Depletion Syndrome, MPV17-Related</td>
            <td>MPV17</td>
            <td>AR \ 256810</td>
        </tr>
        <tr>
            <td>Ataxia-telangiectasia-like disorder 1</td>
            <td>MRE11</td>
            <td>AR \ 604391</td>
        </tr>
        <tr>
            <td>Homocystinuria due to Deficiency of MTHFR</td>
            <td>MTHFR</td>
            <td>AR \ 236250</td>
        </tr>
        <tr>
            <td>Myotubular Myopathy, X-Linked</td>
            <td>MTM1</td>
            <td>XLR \ 310400</td>
        </tr>
        <tr>
            <td>Homocystinuria, Type cblE</td>
            <td>MTRR</td>
            <td>AR \ 236270</td>
        </tr>
        <tr>
            <td>Abetalipoproteinemia</td>
            <td>MTTP</td>
            <td>AR \ 200100</td>
        </tr>
        <tr>
            <td>Methylmalonic Aciduria, Type mut(0)</td>
            <td>MUT</td>
            <td>AR \ 251000</td>
        </tr>
        <tr>
            <td>Deafness, autosomal recessive, 3</td>
            <td>MYO15A</td>
            <td>AR \ 600316</td>
        </tr>
        <tr>
            <td>Usher Syndrome, Type 1B</td>
            <td>MYO7A</td>
            <td>AR \ 276900</td>
        </tr>
        <tr>
            <td>Mucopolysaccharidosis, Type IIIB (Sanfilippo B)</td>
            <td>NAGLU</td>
            <td>AR \ 252920</td>
        </tr>
        <tr>
            <td>N-acetylglutamate Synthase Deficiency</td>
            <td>NAGS</td>
            <td>AR \ 237310</td>
        </tr>
        <tr>
            <td>Nijmegen Breakage Syndrome</td>
            <td>NBN</td>
            <td>AR \ 251260</td>
        </tr>
        <tr>
            <td>Charcot-Marie-Tooth Disease type 4D</td>
            <td>NDRG1</td>
            <td>AR \ 601455</td>
        </tr>
        <tr>
            <td>Mitochondrial Complex I Deficiency, NDUFAF5-Related</td>
            <td>NDUFAF5</td>
            <td>AR \ 618238</td>
        </tr>
        <tr>
            <td>Mitochondrial complex I deficiency</td>
            <td>NDUFS4</td>
            <td>AR \ 252010</td>
        </tr>
        <tr>
            <td>Mitochondrial Complex I Deficiency, NDUFS6-Related</td>
            <td>NDUFS6</td>
            <td>AR \ 618232</td>
        </tr>
        <tr>
            <td>Sialidosis</td>
            <td>NEU1</td>
            <td>AR \ 256550</td>
        </tr>
        <tr>
            <td>Hydatidiform Mole, Recurrent</td>
            <td>NLRP7</td>
            <td>AR \ 231090</td>
        </tr>
        <tr>
            <td>Niemann-Pick Disease, Type C1/D</td>
            <td>NPC1</td>
            <td>AR \ 257220</td>
        </tr>
        <tr>
            <td>Niemann-Pick Disease, Type C2</td>
            <td>NPC2</td>
            <td>AR \ 607625</td>
        </tr>
        <tr>
            <td>Juvenile Nephronophthisis</td>
            <td>NPHP1</td>
            <td>AR \ 256100</td>
        </tr>
        <tr>
            <td>Congenital Finnish Nephrosis</td>
            <td>NPHS1</td>
            <td>AR \ 256300</td>
        </tr>
        <tr>
            <td>Steroid-Resistant Nephrotic Syndrome</td>
            <td>NPHS2</td>
            <td>AR \ 600995</td>
        </tr>
        <tr>
            <td>Congenital Adrenal Hypoplasia, X-linked</td>
            <td>NR0B1</td>
            <td>XLR \ 300200</td>
        </tr>
        <tr>
            <td>Enhanced S-Cone Syndrome</td>
            <td>NR2E3</td>
            <td>AR \ 268100</td>
        </tr>
        <tr>
            <td>Congenital Insensitivity to Pain with Anhidrosis (CIPA)</td>
            <td>NTRK1</td>
            <td>AR \ 256800</td>
        </tr>
        <tr>
            <td>Ornithine Aminotransferase Deficiency</td>
            <td>OAT</td>
            <td>AR \ 258870</td>
        </tr>
        <tr>
            <td>Lowe syndrome, X-Linked</td>
            <td>OCRL</td>
            <td>XLR \ 309000</td>
        </tr>
        <tr>
            <td>Costeff Syndrome (3-Methylglutaconic Aciduria, Type 3)</td>
            <td>OPA3</td>
            <td>AR \ 258501</td>
        </tr>
        <tr>
            <td>Ornithine Transcarbamylase Deficiency</td>
            <td>OTC</td>
            <td>XL \ 311250</td>
        </tr>
        <tr>
            <td>Pantothenate Kinase-Associated Neurodegeneration</td>
            <td>PANK2</td>
            <td>AR \ 234200</td>
        </tr>
        <tr>
            <td>Pyruvate Carboxylase Deficiency</td>
            <td>PC</td>
            <td>AR \ 266150</td>
        </tr>
        <tr>
            <td>Propionic Acidemia, PCCA-Related</td>
            <td>PCCA</td>
            <td>AR \ 606054</td>
        </tr>
        <tr>
            <td>Propionic Acidemia, PCCB-Related</td>
            <td>PCCB</td>
            <td>AR \ 606054</td>
        </tr>
        <tr>
            <td>Pyruvate Dehydrogenase Deficiency, X-Linked</td>
            <td>PDHA1</td>
            <td>XLD \ 312170</td>
        </tr>
        <tr>
            <td>Pyruvate Dehydrogenase Deficiency, PDHB-Related</td>
            <td>PDHB</td>
            <td>AR \ 614111</td>
        </tr>
        <tr>
            <td>Prolidase deficiency</td>
            <td>PEPD</td>
            <td>AR \ 170100</td>
        </tr>
        <tr>
            <td>Cytochrome-c oxidase deficiency</td>
            <td>PET100</td>
            <td>AR \ 619055</td>
        </tr>
        <tr>
            <td>Peroxisome Biogenesis Disorder 1A (Zellweger)</td>
            <td>PEX1</td>
            <td>AR \ 214100</td>
        </tr>
        <tr>
            <td>Peroxisome Biogenesis Disorder 6A (Zellweger)</td>
            <td>PEX10</td>
            <td>AR \ 614870</td>
        </tr>
        <tr>
            <td>Peroxisome Biogenesis Disorder 3A (Zellweger)</td>
            <td>PEX12</td>
            <td>AR \ 614859</td>
        </tr>
        <tr>
            <td>Peroxisome Biogenesis Disorder 5A (Zellweger)</td>
            <td>PEX2</td>
            <td>AR \ 614866</td>
        </tr>
        <tr>
            <td>Peroxisome Biogenesis Disorder 4A (Zellweger)</td>
            <td>PEX6</td>
            <td>AR \ 614862</td>
        </tr>
        <tr>
            <td>Rhizomelic Chondrodysplasia Punctata, Type 1</td>
            <td>PEX7</td>
            <td>AR \ 215100</td>
        </tr>
        <tr>
            <td>Glycogen Storage Disease, Type VII</td>
            <td>PFKM</td>
            <td>AR \ 232800</td>
        </tr>
        <tr>
            <td>Phosphoglycerate Dehydrogenase Deficiency</td>
            <td>PHGDH</td>
            <td>AR \ 601815</td>
        </tr>
        <tr>
            <td>Multiple congenital anomalies-hypotonia-seizures syndrome 1</td>
            <td>PIGN</td>
            <td>AR \ 614080</td>
        </tr>
        <tr>
            <td>Polycystic Kidney Disease, Autosomal Recessive</td>
            <td>PKHD1</td>
            <td>AR \ 263200</td>
        </tr>
        <tr>
            <td>Infantile neuroaxonal dystrophy 1</td>
            <td>PLA2G6</td>
            <td>AR \ 256600</td>
        </tr>
        <tr>
            <td>Congenital Disorder of Glycosylation, Type 1A, PMM2-Related</td>
            <td>PMM2</td>
            <td>AR \ 212065</td>
        </tr>
        <tr>
            <td>Pyridoxal 5&#39;-phosphate-dependent epilepsy</td>
            <td>PNPO</td>
            <td>AR \ 610090</td>
        </tr>
        <tr>
            <td>POLG-Related Disorders</td>
            <td>POLG</td>
            <td>AR \ 203700,  613662, 607459, 258450</td>
        </tr>
        <tr>
            <td>Xeroderma pigmentosum Variant</td>
            <td>POLH</td>
            <td>AR \ 278750</td>
        </tr>
        <tr>
            <td>Muscle-Eye-Brain Disease, POMGNT1-Related</td>
            <td>POMGNT1</td>
            <td>AR \ 253280</td>
        </tr>
        <tr>
            <td>Cytochrome P450 oxidoreductase deficiency</td>
            <td>POR</td>
            <td>AR \ 613571</td>
        </tr>
        <tr>
            <td>Ceroid Lipofuscinosis, Neuronal, 1</td>
            <td>PPT1</td>
            <td>AR \ 256730</td>
        </tr>
        <tr>
            <td>Combined Pituitary Hormone Deficiency 2</td>
            <td>PROP1</td>
            <td>AR \ 262600</td>
        </tr>
        <tr>
            <td>Arts syndrome, X-Linked</td>
            <td>PRPS1</td>
            <td>AR \ 301835</td>
        </tr>
        <tr>
            <td>Metachromatic Leukodystrophy, PSAP-Related</td>
            <td>PSAP</td>
            <td>AR \ 249900</td>
        </tr>
        <tr>
            <td>6-Pyruvoyl-Tetrahydropterin Synthase (PTPS) Deficiency</td>
            <td>PTS</td>
            <td>AR \ 261640</td>
        </tr>
        <tr>
            <td>Mitochondrial Myopathy and Sideroblastic Anemia (MLASA1)</td>
            <td>PUS1</td>
            <td>AR \ 600462</td>
        </tr>
        <tr>
            <td>Glycogen Storage Disease, Type V (McArdle Disease)</td>
            <td>PYGM</td>
            <td>AR \ 232600</td>
        </tr>
        <tr>
            <td>Carpenter Syndrome</td>
            <td>RAB23</td>
            <td>AR \ 201000</td>
        </tr>
        <tr>
            <td>Omenn Syndrome, RAG1-Related</td>
            <td>RAG1</td>
            <td>AR \ 603554</td>
        </tr>
        <tr>
            <td>Omenn Syndrome, RAG2-Related</td>
            <td>RAG2</td>
            <td>AR \ 603554</td>
        </tr>
        <tr>
            <td>Congenital Myasthenic Syndrome, RAPSN-Related</td>
            <td>RAPSN</td>
            <td>AR \ 616326</td>
        </tr>
        <tr>
            <td>Pontocerebellar Hypoplasia, Type 1 and 6, RARS2-Related</td>
            <td>RARS2</td>
            <td>AR \ 611523</td>
        </tr>
        <tr>
            <td>Leber Congenital Amaurosis, Type RDH12</td>
            <td>RDH12</td>
            <td>AD,AR \ 612712</td>
        </tr>
        <tr>
            <td>Retinal Dystrophies, RLBP1-Associated</td>
            <td>RLBP1</td>
            <td>AD,AR \ 607475, 136880, 607476, 136880</td>
        </tr>
        <tr>
            <td>Cartilage-Hair Hypoplasia</td>
            <td>RMRP</td>
            <td>AR \ 250250</td>
        </tr>
        <tr>
            <td>Aicardi-Goutieres syndrome, RNASEH2C-related</td>
            <td>RNASEH2C</td>
            <td>AR \ 610329</td>
        </tr>
        <tr>
            <td>Leber Congenital Amaurosis 2</td>
            <td>RPE65</td>
            <td>AR \ 204100</td>
        </tr>
        <tr>
            <td>Juvenile Retinoschisis, X-Linked</td>
            <td>RS1</td>
            <td>XLR \ 312700</td>
        </tr>
        <tr>
            <td>Dyskeratosis Congenita, RTEL1-Related</td>
            <td>RTEL1</td>
            <td>AD,AR \ 615190</td>
        </tr>
        <tr>
            <td>Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay</td>
            <td>SACS</td>
            <td>AR \ 270550</td>
        </tr>
        <tr>
            <td>MIRAGE syndrome</td>
            <td>SAMD9</td>
            <td>AD \ 617053</td>
        </tr>
        <tr>
            <td>Shwachman-Diamond syndrome</td>
            <td>SBDS</td>
            <td>AR \ 260400</td>
        </tr>
        <tr>
            <td>Pontocerebellar Hypoplasia, Type 2D</td>
            <td>SEPSECS</td>
            <td>AR \ 613811</td>
        </tr>
        <tr>
            <td>Alpha-1-Antitrypsin Deficiency</td>
            <td>SERPINA1</td>
            <td>AR \ 613490</td>
        </tr>
        <tr>
            <td>Limb-Girdle Muscular Dystrophy, Type 2D</td>
            <td>SGCA</td>
            <td>AR \ 608099</td>
        </tr>
        <tr>
            <td>Limb-Girdle Muscular Dystrophy, Type 2E</td>
            <td>SGCB</td>
            <td>AR \ 604286</td>
        </tr>
        <tr>
            <td>Limb-Girdle Muscular Dystrophy, Type 2F</td>
            <td>SGCD</td>
            <td>AR \ 601287</td>
        </tr>
        <tr>
            <td>Limb-Girdle Muscular Dystrophy, Type 2C</td>
            <td>SGCG</td>
            <td>AR \ 253700</td>
        </tr>
        <tr>
            <td>Mucopolysaccharidosis, Type IIIA (Sanfilippo A)</td>
            <td>SGSH</td>
            <td>AR \ 252900</td>
        </tr>
        <tr>
            <td>Gitelman Syndrome</td>
            <td>SLC12A3</td>
            <td>AR \ 263800</td>
        </tr>
        <tr>
            <td>Agenesis of the Corpus Callosum with Peripheral  Neuropathy (Andermann Syndrome)</td>
            <td>SLC12A6</td>
            <td>AR \ 218000</td>
        </tr>
        <tr>
            <td>Salla Disease</td>
            <td>SLC17A5</td>
            <td>AR \ 604369</td>
        </tr>
        <tr>
            <td>Megaloblastic Anemia Syndrome</td>
            <td>SLC19A2</td>
            <td>AR \ 249270</td>
        </tr>
        <tr>
            <td>Carnitine Deficiency</td>
            <td>SLC22A5</td>
            <td>AR \ 212140</td>
        </tr>
        <tr>
            <td>Citrullinemia, Type II</td>
            <td>SLC25A13</td>
            <td>AR \ 603471</td>
        </tr>
        <tr>
            <td>Hyperornithinemia-Hyperammonemia-Homocitrullinuria (HHH) Syndrome</td>
            <td>SLC25A15</td>
            <td>AR \ 238970</td>
        </tr>
        <tr>
            <td>Carnitine-acylcarnitine translocase deficiency</td>
            <td>SLC25A20</td>
            <td>AR \ 212138</td>
        </tr>
        <tr>
            <td>Achondrogenesis, Type 1B</td>
            <td>SLC26A2</td>
            <td>AR \ 600972</td>
        </tr>
        <tr>
            <td>Congenital Chloride Diarrhea</td>
            <td>SLC26A3</td>
            <td>AR \ 214700</td>
        </tr>
        <tr>
            <td>Pendred Syndrome</td>
            <td>SLC26A4</td>
            <td>AR \ 274600</td>
        </tr>
        <tr>
            <td>Autism Spectrum, Epilepsy and Arthrogryposis</td>
            <td>SLC35A3</td>
            <td>AR \ 615553</td>
        </tr>
        <tr>
            <td>Glycogen Storage Disease, Type IB</td>
            <td>SLC37A4</td>
            <td>AR \ 232220</td>
        </tr>
        <tr>
            <td>Acrodermatitis Enteropathica</td>
            <td>SLC39A4</td>
            <td>AR \ 201100</td>
        </tr>
        <tr>
            <td>Oculocutaneous albinism, Type 4</td>
            <td>SLC45A2</td>
            <td>AR \ 606574</td>
        </tr>
        <tr>
            <td>Corneal Dystrophy and Perceptive Deafness</td>
            <td>SLC4A11</td>
            <td>AR \ 217400 , 217700</td>
        </tr>
        <tr>
            <td>Creatine Transporter Defect (Cerebral Creatine Deficiency Syndrome 1, X-Linked)</td>
            <td>SLC6A8</td>
            <td>XLR \ 300352</td>
        </tr>
        <tr>
            <td>Lysinuric Protein Intolerance</td>
            <td>SLC7A7</td>
            <td>AR \ 222700</td>
        </tr>
        <tr>
            <td>Cystinuria, Type B</td>
            <td>SLC7A9</td>
            <td>AR \ 220100</td>
        </tr>
        <tr>
            <td>Schimke Immunoosseous Dysplasia</td>
            <td>SMARCAL1</td>
            <td>AR \ 242900</td>
        </tr>
        <tr>
            <td>Niemann-Pick Disease, Types A/B</td>
            <td>SMPD1</td>
            <td>AR \ 257200, 607616</td>
        </tr>
        <tr>
            <td>5-alpha reductase deficiency</td>
            <td>SRD5A2</td>
            <td>AR \ 264600</td>
        </tr>
        <tr>
            <td>GM3 synthase deficiency</td>
            <td>ST3GAL5</td>
            <td>AR \ 609056</td>
        </tr>
        <tr>
            <td>Lipoid Congenital Adrenal Hyperplasia</td>
            <td>STAR</td>
            <td>AR \ 201710</td>
        </tr>
        <tr>
            <td>Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)</td>
            <td>SUCLA2</td>
            <td>AR \ 612073</td>
        </tr>
        <tr>
            <td>Multiple Sulfatase Deficiency</td>
            <td>SUMF1</td>
            <td>AR \ 272200</td>
        </tr>
        <tr>
            <td>Leigh Syndrome</td>
            <td>SURF1</td>
            <td>AR \ 220110</td>
        </tr>
        <tr>
            <td>Tyrosinemia, Type II</td>
            <td>TAT</td>
            <td>AR \ 276600</td>
        </tr>
        <tr>
            <td>Osteopetrosis, Infantile Malignant, TCIRG1-Related</td>
            <td>TCIRG1</td>
            <td>AR \ 259700</td>
        </tr>
        <tr>
            <td>Hereditary Spastic Paraparesis, Type 49</td>
            <td>TECPR2</td>
            <td>AR \ 615031</td>
        </tr>
        <tr>
            <td>Hemochromatosis, Type 3, TFR2-Related</td>
            <td>TFR2</td>
            <td>AR \ 604250</td>
        </tr>
        <tr>
            <td>Lamellar Ichthyosis, Type 1</td>
            <td>TGM1</td>
            <td>AR \ 242300</td>
        </tr>
        <tr>
            <td>Segawa Syndrome, TH-Related</td>
            <td>TH</td>
            <td>AR \ 605407</td>
        </tr>
        <tr>
            <td>Deafness, autosomal dominant 36, autosomal recessive 7</td>
            <td>TMC1</td>
            <td>AR \ 600974</td>
        </tr>
        <tr>
            <td>Joubert Syndrome 2 / Meckel Syndrome 2</td>
            <td>TMEM216</td>
            <td>AR \ 608091, 603194</td>
        </tr>
        <tr>
            <td>Congenital hypothyroidism</td>
            <td>TPO</td>
            <td>AR \ 274500</td>
        </tr>
        <tr>
            <td>Ceroid Lipofuscinosis, Neuronal, 2</td>
            <td>TPP1</td>
            <td>AR \ 204500</td>
        </tr>
        <tr>
            <td>Aicardi-Goutieres syndrome, TREX1-related</td>
            <td>TREX1</td>
            <td>AD,AR \ 225750</td>
        </tr>
        <tr>
            <td>Bardet-Biedl syndrome 11</td>
            <td>TRIM32</td>
            <td>AR \ 615988</td>
        </tr>
        <tr>
            <td>Mulibrey nanism syndrome</td>
            <td>TRIM37</td>
            <td>AR \ 253250</td>
        </tr>
        <tr>
            <td>Acute Infantile Liver Failure, TRMU-Related</td>
            <td>TRMU</td>
            <td>AR \ 613070</td>
        </tr>
        <tr>
            <td>Pontocerebellar hypoplasia</td>
            <td>TSEN54</td>
            <td>AR \ 610204,  277470,  225753</td>
        </tr>
        <tr>
            <td>Combined Oxidative Phosphorylation Deficiency 3</td>
            <td>TSFM</td>
            <td>AR \ 610505</td>
        </tr>
        <tr>
            <td>Congenital hypothyroidism</td>
            <td>TSHB</td>
            <td>AR \ 275100</td>
        </tr>
        <tr>
            <td>Hypothyroidism, congenital, nongoitrous, 1</td>
            <td>TSHR</td>
            <td>AR \ 275200</td>
        </tr>
        <tr>
            <td>Tricho-Hepato-Enteric Syndrome</td>
            <td>TTC37</td>
            <td>AR \ 222470</td>
        </tr>
        <tr>
            <td>Familial dilated cardiomyopathy</td>
            <td>TTN</td>
            <td>AR \ 611705</td>
        </tr>
        <tr>
            <td>Ataxia with Vitamin E Deficiency</td>
            <td>TTPA</td>
            <td>AR \ 277460</td>
        </tr>
        <tr>
            <td>Myoneurogastrointestinal Encephalopathy (MNGIE)</td>
            <td>TYMP</td>
            <td>AR \ 603041</td>
        </tr>
        <tr>
            <td>Oculocutaneous Albinism, Type 1</td>
            <td>TYR</td>
            <td>AR \ 606952</td>
        </tr>
        <tr>
            <td>Oculocutaneous albinism, Type 3</td>
            <td>TYRP1</td>
            <td>AR \ 203290</td>
        </tr>
        <tr>
            <td>Crigler-Najjar Syndrome</td>
            <td>UGT1A1</td>
            <td>AR \ 218800, 606785</td>
        </tr>
        <tr>
            <td>Beta-ureidopropionase deficiency</td>
            <td>UPB1</td>
            <td>AR \ 613161</td>
        </tr>
        <tr>
            <td>Usher Syndrome, Type 1C</td>
            <td>USH1C</td>
            <td>AR \ 276904</td>
        </tr>
        <tr>
            <td>Cohen Syndrome</td>
            <td>VPS13B</td>
            <td>AR \ 216550</td>
        </tr>
        <tr>
            <td>Congenital Neutropenia, VPS45-Related</td>
            <td>VPS45</td>
            <td>AR \ 615285</td>
        </tr>
        <tr>
            <td>Pontocerebellar Hypoplasia, Type 2E</td>
            <td>VPS53</td>
            <td>AR \ 615851</td>
        </tr>
        <tr>
            <td>Pontocerebellar Hypoplasia, Type 1A</td>
            <td>VRK1</td>
            <td>AR \ 607596</td>
        </tr>
        <tr>
            <td>Microphthalmia/Anophthalmia, VSX2-Related</td>
            <td>VSX2</td>
            <td>AR \ 610093 , 610092</td>
        </tr>
        <tr>
            <td>Von Willebrand disease</td>
            <td>VWF</td>
            <td>AR \ 277480, 613554</td>
        </tr>
        <tr>
            <td>Wiskott-Aldrich syndrome, X-Linked</td>
            <td>WAS</td>
            <td>XLR \ 301000</td>
        </tr>
        <tr>
            <td>Progressive Pseudorheumatoid Dysplasia</td>
            <td>WISP3</td>
            <td>AR \ 208230</td>
        </tr>
        <tr>
            <td>Odonto-Onycho-Dermal Dysplasia / Schopf-Schulz-Passarge Syndrome</td>
            <td>WNT10A</td>
            <td>AR \ 257980</td>
        </tr>
        <tr>
            <td>Werner Syndrome</td>
            <td>WRN</td>
            <td>AR \ 277700</td>
        </tr>
        <tr>
            <td>Xeroderma pigmentosum Group A</td>
            <td>XPA</td>
            <td>AR \ 278700</td>
        </tr>
        <tr>
            <td>Xeroderma Pigmentosum Group C</td>
            <td>XPC</td>
            <td>AR \ 278720</td>
        </tr>
        <tr>
            <td>Spastic Paraplegia Type 15</td>
            <td>ZFYVE26</td>
            <td>AR \ 270700</td>
        </tr>
        <tr>
            <td>3-hydroxyacyl-CoA dehydrogenase deficiency</td>
            <td>HADH</td>
            <td>AR \ 231530</td>
        </tr>
        <tr>
            <td>3-methylglutaconic aciduria, type I</td>
            <td>AUH</td>
            <td>AR \ 250950</td>
        </tr>
        <tr>
            <td>3-methylglutaconic aciduria, type V</td>
            <td>DNAJC19</td>
            <td>AR \ 610198</td>
        </tr>
        <tr>
            <td>?ABCD syndrome</td>
            <td>EDNRB</td>
            <td>AR \ 600501</td>
        </tr>
        <tr>
            <td>Afibrinogenemia, congenital</td>
            <td>FGA</td>
            <td>AR \ 202400</td>
        </tr>
        <tr>
            <td>Afibrinogenemia, congenital</td>
            <td>FGB</td>
            <td>AR \ 202400</td>
        </tr>
        <tr>
            <td>Afibrinogenemia, congenital</td>
            <td>FGG</td>
            <td>AR \ 202400</td>
        </tr>
        <tr>
            <td>AICA-ribosiduria due to ATIC deficiency</td>
            <td>ATIC</td>
            <td>AR \608688</td>
        </tr>
        <tr>
            <td>Allan-Herndon-Dudley syndrome AHDS  </td>
            <td>SLC16A2</td>
            <td>XL \ 300523</td>
        </tr>
        <tr>
            <td>Amyotrophic lateral sclerosis 2, juvenile</td>
            <td>ALS2</td>
            <td>AR \ 205100</td>
        </tr>
        <tr>
            <td>Aromatic L-amino acid decarboxylase deficiency</td>
            <td>DDC</td>
            <td>AR \ 608643</td>
        </tr>
        <tr>
            <td>Arterial calcification, generalized, of infancy, 1</td>
            <td>ENPP1</td>
            <td>AR \ 208000</td>
        </tr>
        <tr>
            <td>Arthrogryposis, renal dysfunction, and cholestasis 1</td>
            <td>VPS33B</td>
            <td>AR \ 208085</td>
        </tr>
        <tr>
            <td>Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia</td>
            <td>APTX</td>
            <td>AR \208920</td>
        </tr>
        <tr>
            <td>Barth syndrome</td>
            <td>TAZ</td>
            <td>XLR \302060</td>
        </tr>
        <tr>
            <td>Bartter syndrome, antenatal, 1</td>
            <td>SLC12A1</td>
            <td>AR \601678 </td>
        </tr>
        <tr>
            <td>Bartter syndrome, antenatal, 2</td>
            <td>KCNJ1</td>
            <td>AR \241200</td>
        </tr>
        <tr>
            <td>3-hydroxyisobutryl-CoA hydrolase deficiency</td>
            <td>HIBCH</td>
            <td>AR \250620</td>
        </tr>
        <tr>
            <td>Bile acid synthesis defect, congenital, 4</td>
            <td>AMACR</td>
            <td>AR \ 214950</td>
        </tr>
        <tr>
            <td>Brittle cornea syndrome 1</td>
            <td>ZNF469</td>
            <td>AR \ 229200</td>
        </tr>
        <tr>
            <td>Mitochondrial complex IV deficiency, nuclear type 2</td>
            <td>SCO2</td>
            <td>AR \ 604377</td>
        </tr>
        <tr>
            <td>Cerebellar hypoplasia, impaired intellectual development, and dysequilibrium syndrome 1</td>
            <td>VLDLR</td>
            <td>AR \ 224050</td>
        </tr>
        <tr>
            <td>Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome</td>
            <td>SNAP29</td>
            <td>AR \609528</td>
        </tr>
        <tr>
            <td>Charcot-Marie-Tooth disease, type 4H</td>
            <td>FGD4</td>
            <td>AR \609311</td>
        </tr>
        <tr>
            <td>Chondrodysplasia punctata, X-linked recessive</td>
            <td>ARSE</td>
            <td>XLR \ 302950</td>
        </tr>
        <tr>
            <td>Chondrodysplasia, Blomstrand type</td>
            <td>PTH1R</td>
            <td>AR \ 215045</td>
        </tr>
        <tr>
            <td>Cirrhosis, cryptogenic</td>
            <td>KRT18</td>
            <td>AR \ 215600</td>
        </tr>
        <tr>
            <td>Coenzyme Q10 deficiency, primary, 4</td>
            <td>CABC1</td>
            <td>AR \ 612016</td>
        </tr>
        <tr>
            <td>Coenzyme Q10 deficiency, primary, 1</td>
            <td>COQ2</td>
            <td>AR \ 607426</td>
        </tr>
        <tr>
            <td>Coenzyme Q10 deficiency, primary, 2</td>
            <td>PDSS1</td>
            <td>AR \ 614651</td>
        </tr>
        <tr>
            <td>Coenzyme Q10 deficiency, primary, 3</td>
            <td>PDSS2</td>
            <td>AR \ 614652</td>
        </tr>
        <tr>
            <td>Adenomas, multiple colorectal</td>
            <td>MUTYH</td>
            <td>AR \ 608456</td>
        </tr>
        <tr>
            <td>Combined oxidative phosphorylation deficiency 2</td>
            <td>MRPS16</td>
            <td>AR \ 610498</td>
        </tr>
        <tr>
            <td>Combined oxidative phosphorylation deficiency 5</td>
            <td>MRPS22</td>
            <td>AR \ 611719</td>
        </tr>
        <tr>
            <td>Congenital disorder of glycosylation, type Ie</td>
            <td>DPM1</td>
            <td>AR \ 608799</td>
        </tr>
        <tr>
            <td>Congenital disorder of glycosylation, type IIa</td>
            <td>MGAT2</td>
            <td>AR \ 212066</td>
        </tr>
        <tr>
            <td>Congenital disorder of glycosylation, type IIb</td>
            <td>MOGS</td>
            <td>AR \ 606056</td>
        </tr>
        <tr>
            <td>Congenital disorder of glycosylation, type IIc</td>
            <td>SLC35C1</td>
            <td>AR \ 266265</td>
        </tr>
        <tr>
            <td>Congenital disorder of glycosylation, type IId</td>
            <td>B4GALT1</td>
            <td>AR \ 607091</td>
        </tr>
        <tr>
            <td>Congenital disorder of glycosylation, type IIf</td>
            <td>SLC35A1</td>
            <td>AR \ 603585</td>
        </tr>
        <tr>
            <td>Congenital disorder of glycosylation, II; CDg1j</td>
            <td>DPAGT1</td>
            <td>AR \ 608093</td>
        </tr>
        <tr>
            <td>Congenital disorder of glycosylation, type Ik</td>
            <td>ALG1</td>
            <td>AR \ 608540</td>
        </tr>
        <tr>
            <td>Congenital disorder of glycosylation, type Im</td>
            <td>DOLK</td>
            <td>AR \ 610768</td>
        </tr>
        <tr>
            <td>Developmental and epileptic encephalopathy 1</td>
            <td>ARX</td>
            <td>XLR \ 308350</td>
        </tr>
        <tr>
            <td>Corpus callosum, agenesis of, with impaired intellectual development, ocular coloboma and micrognathia</td>
            <td>IGBP1</td>
            <td>XLR \ 300472</td>
        </tr>
        <tr>
            <td>Corpus callosum, partial agenesis</td>
            <td>L1CAM</td>
            <td>XLR \ 304100</td>
        </tr>
        <tr>
            <td>Cold-induced sweating syndrome 1</td>
            <td>CRLF1</td>
            <td>AR \ 272430</td>
        </tr>
        <tr>
            <td>Cutis laxa, autosomal recessive, type IB</td>
            <td>EFEMP2</td>
            <td>AR \ 614437</td>
        </tr>
        <tr>
            <td>Cutis laxa, autosomal recessive, type IA</td>
            <td>FBLN5</td>
            <td>AR \ 219100</td>
        </tr>
        <tr>
            <td>Cutis laxa, autosomal recessive, type IIA</td>
            <td>ATP6V0A2</td>
            <td>AR \219200 </td>
        </tr>
        <tr>
            <td>D-2-hydroxyglutaric aciduria</td>
            <td>D2HGDH</td>
            <td>AR \ 600721</td>
        </tr>
        <tr>
            <td>Desmosterolosis</td>
            <td>DHCR24</td>
            <td>AR \ 602398</td>
        </tr>
        <tr>
            <td>Diarrhea 4, malabsorptive, congenital</td>
            <td>NEUROG3</td>
            <td>AR \ 610370</td>
        </tr>
        <tr>
            <td>Donnai-Barrow syndrome</td>
            <td>LRP2</td>
            <td>AR \ 222448</td>
        </tr>
        <tr>
            <td>Donohue syndrome</td>
            <td>INSR</td>
            <td>AR \ 246200</td>
        </tr>
        <tr>
            <td>Anemia, X-linked, with/without neutropenia and/or platelet abnormalities, Hemolytic anemia due to elevated adenosine deaminase, Thrombocytopenia with beta-thalassemia, X-linked, Thrombocytopenia, X-linked, with or without dyserythropoietic anemia</td>
            <td>GATA1</td>
            <td>AR \ 300835, 301083, 314050, 300367</td>
        </tr>
        <tr>
            <td>Dyssegmental dysplasia, Silverman-Handmaker type</td>
            <td>HSPG2</td>
            <td>AR \ 224410</td>
        </tr>
        <tr>
            <td>Ectodermal dysplasia and immunodeficiency 1</td>
            <td>IKBKG</td>
            <td>XLR \ 300291</td>
        </tr>
        <tr>
            <td>Ehlers-Danlos syndrome, cardiac valvular type</td>
            <td>COL1A2</td>
            <td>AR \ 225320</td>
        </tr>
        <tr>
            <td>Griscelli syndrome, type 1</td>
            <td>MYO5A</td>
            <td>AR \ 214450</td>
        </tr>
        <tr>
            <td>Epidermolysis bullosa, junctional 6, with pyloric atresia</td>
            <td>ITGA6</td>
            <td>AR \ 619817</td>
        </tr>
        <tr>
            <td>Epidermolysis bullosa, junctional 5B, with pyloric atresia</td>
            <td>ITGB4</td>
            <td>AR \ 226730</td>
        </tr>
        <tr>
            <td>Epidermolysis bullosa simplex 5B, with muscular dystrophy</td>
            <td>PLEC1</td>
            <td>AR \ 226670</td>
        </tr>
        <tr>
            <td>Epidermolysis bullosa, junctional 4, intermediate</td>
            <td>COL17A1</td>
            <td>AR \ 619787</td>
        </tr>
        <tr>
            <td>Epidermolysis bullosa, lethal acantholytic</td>
            <td>DSP</td>
            <td>AR \ 609638</td>
        </tr>
        <tr>
            <td>Epilepsy, progressive myoclonic 3, with or without intracellular inclusions</td>
            <td>KCTD7</td>
            <td>AR \ 611726</td>
        </tr>
        <tr>
            <td>Developmental and epileptic encephalopathy 2</td>
            <td>CDKL5</td>
            <td>XLD \ 300672</td>
        </tr>
        <tr>
            <td>Developmental and epileptic encephalopathy 3</td>
            <td>SLC25A22</td>
            <td>AR \ 609304</td>
        </tr>
        <tr>
            <td>Developmental and epileptic encephalopathy 4</td>
            <td>STXBP1</td>
            <td>AR \ 612164</td>
        </tr>
        <tr>
            <td>Hyaline fibromatosis syndrome</td>
            <td>ANTXR2</td>
            <td>AR \ 228600</td>
        </tr>
        <tr>
            <td>Ulna and fibula, absence of, with severe limb deficiency</td>
            <td>WNT7A</td>
            <td>AR \ 276820</td>
        </tr>
        <tr>
            <td>Fraser syndrome 1</td>
            <td>FRAS1</td>
            <td>AR \ 219000</td>
        </tr>
        <tr>
            <td>Fraser syndrome 2</td>
            <td>FREM2</td>
            <td>AR \ 617666</td>
        </tr>
        <tr>
            <td>Fucosidosis</td>
            <td>FUCA1</td>
            <td>AR \ 230000</td>
        </tr>
        <tr>
            <td>Geleophysic dysplasia 1</td>
            <td>ADAMTSL2</td>
            <td>AR \ 231050</td>
        </tr>
        <tr>
            <td>Glutathione synthetase deficiency</td>
            <td>GSS</td>
            <td>AR \ 266130</td>
        </tr>
        <tr>
            <td>Multiple mitochondrial dysfunctions syndrome 7</td>
            <td>GCSH</td>
            <td>AR \ 620423</td>
        </tr>
        <tr>
            <td>Dursun syndrome, Neutropenia, severe congenital 4, autosomal recessive</td>
            <td>G6PC3</td>
            <td>AR \ 612541</td>
        </tr>
        <tr>
            <td>Griscelli syndrome, type 2</td>
            <td>RAB27A</td>
            <td>AR \ 607624</td>
        </tr>
        <tr>
            <td>Hemochromatosis, type 2B</td>
            <td>HAMP</td>
            <td>AR \ 613313</td>
        </tr>
        <tr>
            <td>Hepatic venoocclusive disease with immunodeficiency</td>
            <td>SP110</td>
            <td>AR \ 235550</td>
        </tr>
        <tr>
            <td>Heterotaxy, visceral, 1, X-linked</td>
            <td>ZIC3</td>
            <td>XLR \ 306955</td>
        </tr>
        <tr>
            <td>Greenberg skeletal dysplasia</td>
            <td>LBR</td>
            <td>AR \ 215140</td>
        </tr>
        <tr>
            <td>Dejerine-Sottas disease</td>
            <td>EGR2</td>
            <td>AR \ 145900</td>
        </tr>
        <tr>
            <td>Dejerine-Sottas disease</td>
            <td>MPZ</td>
            <td>AR \ 145900</td>
        </tr>
        <tr>
            <td>Dejerine-Sottas disease</td>
            <td>PMP22</td>
            <td>AR \ 145900</td>
        </tr>
        <tr>
            <td>Dejerine-Sottas disease</td>
            <td>PRX</td>
            <td>AR \ 145900</td>
        </tr>
        <tr>
            <td>Hypomagnesemia 5, renal, with ocular involvement</td>
            <td>CLDN19</td>
            <td>AR \ 248190</td>
        </tr>
        <tr>
            <td>Hypoparathyroidism-retardation-dysmorphism syndrome</td>
            <td>TBCE</td>
            <td>AR \ 241410</td>
        </tr>
        <tr>
            <td>Hypophosphatemic rickets, AR</td>
            <td>DMP1</td>
            <td>AR \ 241520</td>
        </tr>
        <tr>
            <td>Craniometaphyseal dysplasia, autosomal recessive, Oculodentodigital dysplasia, autosomal recessive</td>
            <td>GJA1</td>
            <td>AR \ 218400 ,257850</td>
        </tr>
        <tr>
            <td>Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis</td>
            <td>CLDN1</td>
            <td>AR \ 607626</td>
        </tr>
        <tr>
            <td>Lethal congenital contractural syndrome 2, Visceral neuropathy, familial, 1, autosomal recessive</td>
            <td>ERBB3</td>
            <td>AR \ 607598, 243180</td>
        </tr>
        <tr>
            <td>Immunodeficiency, X-linked, with hyper-IgM</td>
            <td>CD40LG</td>
            <td>AR \ 308230</td>
        </tr>
        <tr>
            <td>Immunodeficiency-centromeric instability-facial anomalies syndrome 1</td>
            <td>DNMT3B</td>
            <td>AR \ 242860</td>
        </tr>
        <tr>
            <td>Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked</td>
            <td>FOXP3</td>
            <td>XLR \ 304790</td>
        </tr>
        <tr>
            <td>Mitochondrial DNA depletion syndrome 7 (hepatocerebral type)</td>
            <td>C10ORF2</td>
            <td>AR \ 271245</td>
        </tr>
        <tr>
            <td>Insulin-like growth factor I deficiency</td>
            <td>IGF1</td>
            <td>AR \ 608747</td>
        </tr>
        <tr>
            <td>Intestinal pseudoobstruction, neuronal</td>
            <td>FLNA</td>
            <td>XLR \ 300048</td>
        </tr>
        <tr>
            <td>Jervell and Lange-Nielsen syndrome</td>
            <td>KCNQ1</td>
            <td>AR \ 220400</td>
        </tr>
        <tr>
            <td>Johanson-Blizzard syndrome</td>
            <td>UBR1</td>
            <td>AR \ 243800</td>
        </tr>
        <tr>
            <td>Joubert syndrome 3</td>
            <td>AHI1</td>
            <td>AR \ 608629</td>
        </tr>
        <tr>
            <td>Joubert syndrome 6</td>
            <td>TMEM67</td>
            <td>AR \ 610688</td>
        </tr>
        <tr>
            <td>Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria)</td>
            <td>SUCLG1</td>
            <td>AR \ 245400</td>
        </tr>
        <tr>
            <td>Lathosterolosis</td>
            <td>SC5DL</td>
            <td>AR \ 607330</td>
        </tr>
        <tr>
            <td>Lesch-Nyhan syndrome</td>
            <td>HPRT1</td>
            <td>XLR \ 300322</td>
        </tr>
        <tr>
            <td>Leukodystrophy, hypomyelinating, 2</td>
            <td>GJC2</td>
            <td>AR \ 608804</td>
        </tr>
        <tr>
            <td>Leukodystrophy, hypomyelinating, 5</td>
            <td>FAM126A</td>
            <td>AR \ 610532</td>
        </tr>
        <tr>
            <td>Lissencephaly 2 (Norman-Roberts type)</td>
            <td>RELN</td>
            <td>AR \ 257320</td>
        </tr>
        <tr>
            <td>Lissencephaly, X-linked</td>
            <td>DCX</td>
            <td>XL \ 300067</td>
        </tr>
        <tr>
            <td>Lujan-Fryns syndrome</td>
            <td>MED12</td>
            <td>XLR \ 309520</td>
        </tr>
        <tr>
            <td>Lymphoproliferative syndrome, X-linked, 1</td>
            <td>SH2D1A</td>
            <td>XLR \ 308240</td>
        </tr>
        <tr>
            <td>Mandibuloacral dysplasia with type B lipodystrophy</td>
            <td>ZMPSTE24</td>
            <td>AR \ 608612</td>
        </tr>
        <tr>
            <td>Marinesco-Sjogren syndrome</td>
            <td>SIL1</td>
            <td>AR \ 248800</td>
        </tr>
        <tr>
            <td>Martsolf syndrome 1</td>
            <td>RAB3GAP2</td>
            <td>AR \ 212720</td>
        </tr>
        <tr>
            <td>Intellectual developmental disorder, X-linked syndromic, Christianson type</td>
            <td>SLC9A6</td>
            <td>XL \ 300243</td>
        </tr>
        <tr>
            <td>Mevalonic aciduria</td>
            <td>MVK</td>
            <td>AR \ 610377</td>
        </tr>
        <tr>
            <td>Microphthalmia, isolated, with coloboma 8</td>
            <td>STRA6</td>
            <td>AR \ 601186</td>
        </tr>
        <tr>
            <td>Mitochondrial complex III deficiency, nuclear type 3</td>
            <td>UQCRB</td>
            <td>AR \ 615158</td>
        </tr>
        <tr>
            <td>Mitochondrial complex III deficiency, nuclear type 4</td>
            <td>UQCRQ</td>
            <td>AR \ 615159</td>
        </tr>
        <tr>
            <td>Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)</td>
            <td>DGUOK</td>
            <td>AR \ 251880</td>
        </tr>
        <tr>
            <td>Mitochondrial DNA depletion syndrome 2 (myopathic type)</td>
            <td>TK2</td>
            <td>AR \609560</td>
        </tr>
        <tr>
            <td>Molybdenum cofactor deficiency B</td>
            <td>MOCS2</td>
            <td>AR \ 252160</td>
        </tr>
        <tr>
            <td>Multiple pterygium syndrome, lethal type</td>
            <td>CHRNA1</td>
            <td>AR \ 253290</td>
        </tr>
        <tr>
            <td>Multiple pterygium syndrome, lethal type</td>
            <td>CHRND</td>
            <td>AR \ 253290</td>
        </tr>
        <tr>
            <td>Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 6</td>
            <td>LARGE</td>
            <td>AR \ 608840</td>
        </tr>
        <tr>
            <td>Myopathy due to myoadenylate deaminase deficiency</td>
            <td>AMPD1</td>
            <td>AR \ 615511</td>
        </tr>
        <tr>
            <td>Myoclonic epilepsy of Lafora 1</td>
            <td>EPM2A</td>
            <td>AR \ 254780</td>
        </tr>
        <tr>
            <td>Myoclonic epilepsy of Lafora 2</td>
            <td>NHLRC1</td>
            <td>AR \ 620681</td>
        </tr>
        <tr>
            <td>Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg)</td>
            <td>CSTB</td>
            <td>AR \ 254800</td>
        </tr>
        <tr>
            <td>Myxoma, intracardiac</td>
            <td>PRKAR1A</td>
            <td>AR \ 255960</td>
        </tr>
        <tr>
            <td>Nemaline myopathy 5B, autosomal recessive, childhood-onset</td>
            <td>TNNT1</td>
            <td>AR \ 620386</td>
        </tr>
        <tr>
            <td>Nephronophthisis 2, infantile</td>
            <td>INVS</td>
            <td>AR \ 602088</td>
        </tr>
        <tr>
            <td>Nephronophthisis 4</td>
            <td>NPHP4</td>
            <td>AR \ 606966</td>
        </tr>
        <tr>
            <td>Nephrotic syndrome, type 3</td>
            <td>PLCE1</td>
            <td>AR \ 610725</td>
        </tr>
        <tr>
            <td>Nephrotic syndrome, type 4</td>
            <td>WT1</td>
            <td>AR \ 256370</td>
        </tr>
        <tr>
            <td>Ehlers-Danlos syndrome, kyphoscoliotic type, 1</td>
            <td>PLOD1</td>
            <td>AR \ 225400</td>
        </tr>
        <tr>
            <td>Norrie disease</td>
            <td>NDP</td>
            <td>XLR \ 310600</td>
        </tr>
        <tr>
            <td>Mohr-Tranebjaerg syndrome</td>
            <td>TIMM8A</td>
            <td>XLR \ 304700</td>
        </tr>
        <tr>
            <td>Osteogenesis imperfecta, type VII</td>
            <td>CRTAP</td>
            <td>AR \ 610682</td>
        </tr>
        <tr>
            <td>Osteogenesis imperfecta, type VIII</td>
            <td>LEPRE1</td>
            <td>AR \ 610915</td>
        </tr>
        <tr>
            <td>Osteopetrosis, autosomal recessive 3, with renal tubular acidosis</td>
            <td>CA2</td>
            <td>AR \ 259730</td>
        </tr>
        <tr>
            <td>Osteopetrosis, autosomal recessive 5</td>
            <td>OSTM1</td>
            <td>AR \ 259720</td>
        </tr>
        <tr>
            <td>Osteoporosis-pseudoglioma syndrome</td>
            <td>LRP5</td>
            <td>AR \ 259770</td>
        </tr>
        <tr>
            <td>Paget disease of bone 5, juvenile-onset</td>
            <td>TNFRSF11B</td>
            <td>AR \ 239000</td>
        </tr>
        <tr>
            <td>Spastic paraplegia 2, X-linked</td>
            <td>PLP1</td>
            <td>XLR \ 312920</td>
        </tr>
        <tr>
            <td>Phosphoserine aminotransferase deficiency</td>
            <td>PSAT1</td>
            <td>AR \ 610992</td>
        </tr>
        <tr>
            <td>Pierson syndrome</td>
            <td>LAMB2</td>
            <td>AR \ 609049</td>
        </tr>
        <tr>
            <td>Pituitary hormone deficiency, combined, 5</td>
            <td>HESX1</td>
            <td>AD,AR \ 182230</td>
        </tr>
        <tr>
            <td>Pituitary hormone deficiency, combined, 3</td>
            <td>LHX3</td>
            <td>AR \ 221750</td>
        </tr>
        <tr>
            <td>Pituitary hormone deficiency, combined or isolated, 1</td>
            <td>POU1F1</td>
            <td>AD,AR \ 613038 </td>
        </tr>
        <tr>
            <td>Plasminogen deficiency, type I</td>
            <td>PLG</td>
            <td>AR \  217090</td>
        </tr>
        <tr>
            <td>Porphyria, congenital erythropoietic</td>
            <td>UROS</td>
            <td>AR \ 263700</td>
        </tr>
        <tr>
            <td>Properdin deficiency, X-linked</td>
            <td>CFP</td>
            <td>XLR \ 312060</td>
        </tr>
        <tr>
            <td>Pseudohypoaldosteronism, type IB1, autosomal recessive</td>
            <td>SCNN1A</td>
            <td>AR \ 264350</td>
        </tr>
        <tr>
            <td>Pseudohypoaldosteronism, type IB2, autosomal recessive</td>
            <td>SCNN1B</td>
            <td>AR \ 620125</td>
        </tr>
        <tr>
            <td>Pseudohypoaldosteronism, i, ar; PHA1</td>
            <td>SCNN1G</td>
            <td>AR \ 620126</td>
        </tr>
        <tr>
            <td>Pulmonary alveolar microlithiasis</td>
            <td>SLC34A2</td>
            <td>AR \ 265100</td>
        </tr>
        <tr>
            <td>Lacticacidemia due to PDX1 deficiency</td>
            <td>PDHX</td>
            <td>AR \ 245349</td>
        </tr>
        <tr>
            <td>Pyruvate dehydrogenase phosphatase deficiency</td>
            <td>PDP1</td>
            <td>AR \ 608782</td>
        </tr>
        <tr>
            <td>Pyruvate kinase deficiency</td>
            <td>PKLR</td>
            <td>AR \ 266200</td>
        </tr>
        <tr>
            <td>Raine syndrome</td>
            <td>FAM20C</td>
            <td>AR \ 259775</td>
        </tr>
        <tr>
            <td>Renal tubular dysgenesis</td>
            <td>ACE</td>
            <td>AR \ 267430</td>
        </tr>
        <tr>
            <td>Renal tubular dysgenesis</td>
            <td>AGT</td>
            <td>AR \ 267430</td>
        </tr>
        <tr>
            <td>Renal tubular dysgenesis</td>
            <td>AGTR1</td>
            <td>AR \ 267430</td>
        </tr>
        <tr>
            <td>Renal tubular dysgenesis</td>
            <td>REN</td>
            <td>AR \ 267430</td>
        </tr>
        <tr>
            <td>Renal-hepatic-pancreatic dysplasia 1</td>
            <td>NPHP3</td>
            <td>AR \ 208540</td>
        </tr>
        <tr>
            <td>Renpenning syndrome 1; RENS1</td>
            <td>PQBP1</td>
            <td>XLR \ 309500</td>
        </tr>
        <tr>
            <td>Interstitial lung disease 1</td>
            <td>SFTPA1</td>
            <td>AR \ 619611</td>
        </tr>
        <tr>
            <td>Surfactant metabolism dysfunction, pulmonary, 1</td>
            <td>SFTPB</td>
            <td>AR \ 265120</td>
        </tr>
        <tr>
            <td>Retinoschisis</td>
            <td>SFTPC</td>
            <td>XLR \ 312700</td>
        </tr>
        <tr>
            <td>Rigid spine muscular dystrophy 1; RSMD1</td>
            <td>SEPN1</td>
            <td>AR \ 602771</td>
        </tr>
        <tr>
            <td>Schindler disease, type I</td>
            <td>NAGA</td>
            <td>AR \ 609241</td>
        </tr>
        <tr>
            <td>Schneckenbecken dysplasia</td>
            <td>SLC35D1</td>
            <td>AR \ 269250</td>
        </tr>
        <tr>
            <td>Seckel syndrome 1</td>
            <td>ATR</td>
            <td>AR \ 210600</td>
        </tr>
        <tr>
            <td>Senior-Loken syndrome 5</td>
            <td>IQCB1</td>
            <td>AR \ 609254</td>
        </tr>
        <tr>
            <td>Severe combined immunodeficiency, autosomal recessive, T-negative/B-positive type</td>
            <td>JAK3</td>
            <td>AR \ 600802</td>
        </tr>
        <tr>
            <td>Simpson-Golabi-Behmel syndrome, type 2</td>
            <td>OFD1</td>
            <td>AR \ 300209</td>
        </tr>
        <tr>
            <td>Neuronopathy, distal hereditary motor, autosomal recessive 1</td>
            <td>IGHMBP2</td>
            <td>AR \ 604320</td>
        </tr>
        <tr>
            <td>Neuronopathy, distal hereditary motor, autosomal recessive 4</td>
            <td>PLEKHG5</td>
            <td>AR \ 611067</td>
        </tr>
        <tr>
            <td>Spinal muscular atrophy, X-linked 2, infantile</td>
            <td>UBA1</td>
            <td>XLR \ 301830</td>
        </tr>
        <tr>
            <td>Spondylocostal dysostosis 1, autosomal recessive</td>
            <td>DLL3</td>
            <td>AR \ 277300</td>
        </tr>
        <tr>
            <td>Striatonigral degeneration, infantile</td>
            <td>NUP62</td>
            <td>AR \ 271930</td>
        </tr>
        <tr>
            <td>Succinic semialdehyde dehydrogenase deficiency</td>
            <td>ALDH5A1</td>
            <td>AR \ 271980</td>
        </tr>
        <tr>
            <td>Sudden infant death with dysgenesis of the testes syndrome</td>
            <td>TSPYL1</td>
            <td>AR \ 608800</td>
        </tr>
        <tr>
            <td>Sulfite oxidase deficiency</td>
            <td>SUOX</td>
            <td>AR \ 272300</td>
        </tr>
        <tr>
            <td>T-cell immunodeficiency, congenital alopecia, and nail dystrophy</td>
            <td>FOXN1</td>
            <td>AR \ 601705</td>
        </tr>
        <tr>
            <td>?Tetra-amelia syndrome 1</td>
            <td>WNT3</td>
            <td>AR \ 273395</td>
        </tr>
        <tr>
            <td>{Budd-Chiari syndrome}, Factor V deficiency</td>
            <td>F5</td>
            <td>AR \  600880, 227400</td>
        </tr>
        <tr>
            <td>Thrombophilia 3 due to protein C deficiency, autosomal recessive</td>
            <td>PROC</td>
            <td>AR \ 612304</td>
        </tr>
        <tr>
            <td>Thrombotic thrombocytopenic purpura, hereditary</td>
            <td>ADAMTS13</td>
            <td>AR \ 274150</td>
        </tr>
        <tr>
            <td>Charcot-Marie-Tooth disease, type 2B1, Mandibuloacral dysplasia</td>
            <td>LMNA</td>
            <td>AR \ 605588, 248370</td>
        </tr>
        <tr>
            <td>Trichothiodystrophy 3, photosensitive</td>
            <td>GTF2H5</td>
            <td>AR \ 616395</td>
        </tr>
        <tr>
            <td>Spermatogenic failure 89</td>
            <td>AK9</td>
            <td>AR \ 620705</td>
        </tr>
	<tr>
            <td>Usher syndrome, type 1G</td>
            <td>USH1G</td>
            <td>AR \ 606943</td>
        </tr>
	<tr>
            <td>?Mosaic variegated aneuploidy syndrome 4</td>
            <td>CENATAC</td>
            <td>AR \ 620153</td>
        </tr>
        <tr>
            <td>Usher syndrome, type IIC, GPR98/PDZD7 digenic</td>
            <td>GPR98</td>
            <td>AR \ 605472</td>
        </tr>
	 <tr>
            <td>Deafness, autosomal recessive 124</td>
            <td>PKHD1L1</td>
            <td>AR \ 620794</td>
        </tr>
        <tr>
            <td>Fanconi anemia, complementation group B</td>
            <td>FANCB</td>
            <td>XLR \ 300514</td>
        </tr>
        <tr>
            <td>Rickets, vitamin D-resistant, type IIA</td>
            <td>VDR</td>
            <td>AR \ 277440</td>
        </tr>
        <tr>
            <td>Waardenburg syndrome, type 4B</td>
            <td>EDN3</td>
            <td>AR \ 613265</td>
        </tr>
	<tr>
            <td>Polydactyly, postaxial, type A10</td>
            <td>KIAA0825</td>
            <td>AR \ 618498</td>
        </tr>
        <tr>
            <td>Waardenburg syndrome, type 4C</td>
            <td>SOX10</td>
            <td>AR \ 613266</td>
        </tr>
        <tr>
            <td>Walker-Warburg syndrome</td>
            <td>POMT1</td>
            <td>AR \ 236670,609308,613155</td>
        </tr>
        <tr>
            <td>Walker-Warburg syndrome</td>
            <td>POMT2</td>
            <td>AR \ 613150,613156,613158</td>
        </tr>
        <tr>
            <td>Warburg micro syndrome 1</td>
            <td>RAB3GAP1</td>
            <td>AR \ 600118</td>
        </tr>
	<tr>
            <td>Thyroid dyshormonogenesis 1</td>
            <td>SLC5A5</td>
            <td>AR \ 274400</td>
        </tr>
	<tr>
            <td>Microcephaly, growth restriction, and increased sister chromatid exchange 2, Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 5</td>
            <td>TOP3A</td>
            <td>AR \ 618097,618098</td>
        </tr>
	<tr>
            <td>Intellectual developmental disorder, autosomal recessive 71</td>
            <td>TOP3A</td>
            <td>AR \618504</td>
        </tr>
	<tr>
            <td>Dworschak-Punetha neurodevelopmental syndrome</td>
            <td>PLXNA1</td>
            <td>AR \ 619955</td>
        </tr>
	<tr>
            <td>Basel-Vanagait-Smirin-Yosef syndrome</td>
            <td>MED25</td>
            <td>AR \ 616449</td>
        </tr>
	<tr>
            <td>Deafness, autosomal recessive 84A</td>
            <td>PTPRQ</td>
            <td>AR \	613391</td>
        </tr>
	      <tr>
            <td>?Epilepsy, progressive myoclonic, 10 </td>
            <td>PRDM8</td>
            <td>AR \ 616640</td>
        </tr>
	       <tr>
            <td>Lipase deficiency, combined </td>
            <td>LMF1</td>
            <td>AR \ 246650</td>
        </tr>
	       <tr>
            <td>Brody myopathy</td>
            <td>ATP2A1</td>
            <td>AR \ 601003</td>
        </tr>
	  <tr>
            <td>Extraoral halitosis due to MTO deficiency</td>
            <td>SELENBP1</td>
            <td>AR \ 618148</td>
        </tr>

    </tbody>
    </table>
  </div>
  <script src="script.js"></script>
</body>
</html>
